Innovation Funding Database

Choose Your Area of Innovation:

  • Advanced Materials & Manufacturing

  • Aerospace & Spacetech

  • Agtech & Foodtech

  • Artificial Intelligence & Machines Learning

  • Biotech

  • Cleantech & Climatetech

  • Cybersecurity

  • Defensetech & Dual-Use Tech

  • eXtended Reality

  • Healthtech

  • Medtech

  • Other Tech

  • Quantum & Photonics

  • Robotics & Autonomous Systems

Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

AFRL Multiple Award Contract (AMAC) – Air Force Research Laboratory

Deadline: February 27, 2026

Funding Award Size: $500 - $50 Million

Description: Funding vehicle enabling AFRL to award unclassified science and technology research task orders across air, space, cyber, and cross-cutting defense domains.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Air Force Research Laboratory (AFRL) AMAC program establishes a multiple-award IDIQ contract vehicle enabling qualified U.S. companies to compete for future AFRL-funded science and technology (S&T) research task orders. There is no funding awarded at the base contract level; funding is provided only through competitively awarded task orders after selection. Proposals are due February 27, 2026.

How much funding would I receive?

There is no fixed funding amount awarded at the base IDIQ level. Each awardee is guaranteed a minimum of $500 over the life of the contract. Actual funding is awarded later through individual task or delivery orders, which may range from small research efforts to very large programs. The estimated ceiling value across all AMAC contracts is $10 billion.

How does the program work?

AMAC is not a single grant but a long-term contract vehicle that allows AFRL to rapidly fund unclassified science and technology research through future task orders. If you meet the criteria, you will receive the long-term contract vehicle. Companies selected to the AMAC vehicle become eligible to compete for AFRL-funded projects covering basic and applied research, technology development, modeling and simulation, manufacturing, experimentation, integration, and technology transition. Importantly, there is no funding awarded upfront—all funding is issued later through individual task orders, each with its own scope, budget, and performance period.

Are there any additional benefits I would receive?

Beyond task-order funding, AMAC awardees gain several indirect but material benefits:

  • Government Validation and Credibility: Selection confirms AFRL validation of your company’s technical experience as a prime contractor.

  • Long-Term AFRL Access: Awardees are eligible to compete for AFRL task orders for up to 8 years.

  • Increased Visibility: Awardees become part of AFRL’s active R&D contractor ecosystem.

  • Non-Dilutive Growth: Task-order funding enables technology maturation without equity dilution.

  • Stronger Strategic Positioning: Proven AFRL work can enhance acquisition, partnership, and future DoD contracting opportunities.

What is the timeline to apply and when would I receive funding?

Proposals must be submitted by February 27, 2026 at 5:00 PM ET. Base IDIQ awards are made after evaluation. Funding is only received after winning individual task orders, which may be issued at any point during the contract’s ordering period.

Where does this funding come from?

Funding for task orders comes from AFRL directorates and partner agencies using AFRL as the contracting vehicle. The base AMAC contract itself does not carry dedicated funding.

Who is eligible to apply?

Eligible applicants include U.S.-based companies that can demonstrate qualifying prime contractor experience in federal S&T research. This includes:

  • Small businesses

  • Large businesses

  • Joint ventures

  • Universities and non-profits

Foreign-owned or foreign-influenced companies are not eligible unless formally approved through the National Industrial Security Program.

What companies will receive the contracting vehicle?

To receive an AMAC award, offerors must:

  • Be a responsible source under FAR Part 9

  • Submit a compliant proposal following Section L instructions

  • Achieve a validated minimum score of 1,000 points in the self-scoring technical experience evaluation here

  • Demonstrate prime contractor experience in AFRL technical Areas of Interest

  • Receive an Acceptable rating for both Technical Experience and Small Business Participation Commitment

There is no price competition at the base contract level.

Are there any restrictions I should know about?

Yes. Key restrictions include:

  • No classified work is permitted under the AMAC base contract

  • Only prime contractor experience counts toward technical scoring

  • Subcontractor experience does not qualify for scoring

How can BW&CO help?

The AMAC solicitation is fundamentally a compliance-driven, pass/fail process. AFRL has stated that any offeror who submits a fully compliant proposal and meets the minimum technical threshold will receive an AMAC contract—while even minor non-compliance can result in elimination, regardless of technical merit. BW&CO helps ensure your proposal is structured correctly, fully compliant, and strategically positioned so you don’t lose this opportunity due to avoidable errors.

How much would BW&CO Charge?

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See the solicitation here.

Read More
Active, specific topic Josiah Wegner Active, specific topic Josiah Wegner

Chemical and Biological Technologies Fundamental Research BAA – Defense Threat Reduction Agency (DTRA)

Deadline: March 2, 2026

Funding Award Size: $300K to $5 Million+

Description: Funding for research advancing chemical and biological defense technologies to counter weapons of mass destruction threats.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Defense Threat Reduction Agency (DTRA) is accepting rolling submissions through 2034 for fundamental research projects that advance chemical and biological defense capabilities. This Broad Agency Announcement (BAA) supports basic and applied research addressing counter–weapons of mass destruction (C-WMD) challenges, with a current white paper deadline of March 2, 2026 for Topic Areas B1–B6.

How much funding would I receive?

$300,000 to $5 million depending on the topic.

What could I use the funding for?

For research and development that aligns with the topics below. For more details on each topic click here.

B1. Deriving Human Physiological Endpoints via Microphysiological Systems (MPS): Bridging the Gap for Predictive Translation

DTRA is seeking fundamental research that advances microphysiological systems (organs-on-a-chip) to derive reliable, human-relevant physiological endpoints that can be translated into real-world exposure detection. Projects should develop standardized, measurable physiological signals across multi-organ MPS platforms and link those signals to in-vivo human responses, particularly for early detection of chemical and biological exposures. Emphasis is placed on novel sensing technologies, data integration, and predictive algorithms rather than therapeutics or animal studies. Read full description here.

B2. Self-Improving AI Systems for Adaptive Defense

This topic funds research into AI systems that can autonomously adapt to new chemical and biological threats without human retraining. DTRA is specifically interested in self-modifying AI architectures that can safely update their own models, structures, or code while maintaining formally verified performance and safety guarantees. Projects must focus on foundational AI theory and methods—such as formal verification, containment, and meta-learning—rather than static or manually retrained detection systems. Read full description here.

B3. Quantum-Enhanced Topological Data Analysis for Chemical and Biological Defense

DTRA seeks interdisciplinary research combining quantum computing and topological data analysis to identify complex patterns in high-dimensional chemical and biological data that classical methods cannot detect. The goal is to enable earlier warning of engineered or novel threats, improve pathogen classification, and accelerate countermeasure discovery. Projects should focus on developing quantum-enabled analytical frameworks and demonstrating clear advantages over classical computational approaches. Read full description here.

B4. Advanced Repellent Materials for Omniphobic Resistance (ARMOR)

This topic supports fundamental research into durable, PFAS-free repellent materials for textiles that resist chemical and biological threats, oils, and industrial contaminants. DTRA is looking for new material chemistries and surface architectures—particularly reentrant or textured surfaces—that achieve strong oil repellency, mechanical durability, and safety for skin contact. Research should emphasize materials science, characterization methods, and performance against chemical simulants rather than full protective suit development. Read full description here.

B5. Sensing Engineered Chemical and Biological Threats with Synthetic Biology Designs

DTRA is funding early-stage research into synthetic biology-based sensing materials that enable rapid, adaptable detection of engineered or emerging biological threats. Projects should integrate computational design, AI/ML, and synthetic biology to create novel affinity reagents or sensing elements that outperform traditional antibodies in speed, adaptability, or stability. The focus is on proof-of-concept platforms and fundamental sensing science, not deployable sensor systems. Read full description here.

B6. Free-Standing Films Used as Detection Wipes

This topic seeks fundamental research on free-standing, self-indicating films that can be used as low-cost detection wipes for chemical threats on surfaces. DTRA is interested in understanding the structural, optical, and electrical properties of cross-linked polymer films embedded with non-dye-based recognition elements that change color upon exposure to chemical agents or simulants. Research should prioritize material synthesis, reproducibility, environmental robustness, and early prototype integration rather than full system fielding. Read full description here.

Are there any additional benefits I would receive?

Beyond the formal funding award, there are significant indirect benefits to receiving a DTRA fundamental research award:

Government Validation and Credibility: Selection by DTRA signals strong technical credibility and alignment with national counter-WMD priorities, which can accelerate trust with defense partners and future government sponsors.

Enhanced Visibility Within the Defense Research Community: Awardees are part of DTRA’s extramural research ecosystem, increasing exposure to DoD laboratories, academic collaborators, and future funding opportunities.

Nondilutive Technology Maturation: By advancing early-stage science with nondilutive funding, companies can de-risk core technology while preserving equity and strengthening long-term exit potential.

What is the timeline to apply and when would I receive funding?

For Topic Areas B1–B6, pre-application white papers are due March 2, 2026 at 11:59 PM EST. Submissions follow a two-phase process, with invited full proposals submitted after successful white paper review.

Where does this funding come from?

Funding is provided by the Department of Defense through the Defense Threat Reduction Agency (DTRA) under CFDA 12.351.

Who is eligible to apply?

Eligibility is defined at the topic level. In general, the BAA supports extramural performers conducting basic or applied research, including universities, industry, and other research organizations, subject to topic-specific requirements. is cost-shared by non-government sources

What companies and projects are likely to win?

Competitive projects typically:

  • Address high-impact chemical or biological defense challenges relevant to C-WMD

  • Advance fundamental scientific knowledge or revolutionary technical approaches

  • Align with early-stage research (TRLs 1–4)

  • Demonstrate strong scientific rigor and feasibility

  • Fit within DTRA’s stated thrust areas or published topic needs

Are there any restrictions I should know about?

Pre-application coordination is generally required before submitting a white paper, and submissions without coordination may not be reviewed. Proprietary product development and later-stage commercialization activities are outside the scope of this announcement.

How long will it take me to prepare an application?

Most first-time applicants (without any assistance from BW&CO) should plan for 40–60 hours of effort to prepare the white paper over 8–12 weeks, including technical writing, budget preparation, and internal reviews.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for $4000 Initial Fee for the white paper.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Learn more about the program here.

Read More
Active, specific topic Josiah Wegner Active, specific topic Josiah Wegner

Compact Oxygen Generation Medical Devices (COGM / COGM-A) – Defense Health Agency (DHA)

Deadline: March 6, 2026

Funding Award Size: Est. $1M to $2M

Description: Funding to develop FDA-cleared compact medical oxygen generation devices for expeditionary and aeromedical military environments under a Defense Health Agency OTA.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Defense Health Agency (DHA) is soliciting prototype proposals to develop compact medical oxygen generation devices for use in austere and expeditionary military environments. This Other Transaction Authority (OTA) program supports the development of FDA-cleared oxygen generation systems for battlefield care and aeromedical evacuation. Proposals are due March 6, 2026.

How much funding would I receive?

Estimated $1-$2 million. The RPP does not specify a minimum or maximum award size. The government anticipates making multiple prototype OTA awards, with funding incrementally obligated over the period of performance. Total award size will depend on proposed scope, schedule, and cost realism.

What could I use the funding for?

The DHA needs to provide medical oxygen solutions in austere environments to treat service members with compromised lung function or injuries requiring oxygen therapy. The WEMT PMO is developing multiple oxygen generation and delivery systems through its Portable Oxygen (O2) program. This program aims to support casualties across all care settings, including evacuation platforms (Roles of Care 1-3 and en route). Development and approval of candidate solutions will adhere to the U.S. Food and Drug Administration (FDA), and other relevant regulatory and industry best practices.

This effort focuses on developing two expeditionary, easy-to-maintain oxygen generation devices meeting Joint Enroute Care Equipment Test Standard and airworthiness standards:

FOCUS AREA #1: Compact Oxygen Generation, Medical (COGM)

• Priority: High

• Primary Use: Role 1 (but still usable across all Roles, including en route care)

• Capabilities: Adjustable flow rate (3-7 lpm minimum, 15 lpm desired) for use with nasal cannulas, face masks, and nebulizers.

• Target Timeline: Regulatory approvals by 2029, procurement by 2031 (shorter timeline preferred)

FOCUS AREA #2: Compact Oxygen Generation, Medical – At Altitude (COGM-A)

• Primary Use: Aeromedical evacuation platforms

• Capabilities: Similar to COGM, but with adjustable flow up to 15 lpm and high-pressure output for ventilators.

• Target Timeline: Regulatory approvals by 2030, procurement by 2032 (shorter timeline preferred)

Are there any additional benefits I would receive?

Beyond the direct funding, awardees gain several strategic advantages:

Government Validation and Credibility:
Selection by the Defense Health Agency signals strong technical credibility and alignment with DoD operational medical priorities—often accelerating trust with military customers, primes, and investors.

Nondilutive Technology Advancement:
This OTA enables companies to mature medical devices without equity dilution, preserving cap table value while advancing toward procurement readiness.

Follow-On Production Potential:
Successful prototypes may lead directly to a follow-on production OTA, reducing acquisition friction and shortening the path to revenue.

Enhanced Defense Market Visibility:
Awardees become part of DHA’s Warfighter Expeditionary Medicine ecosystem, increasing exposure across DoD medical and acquisition communities..

What is the timeline to apply and when would I receive funding?

  1. Questions Due: February 6, 2026

  2. Proposals Due: March 6, 2026 (5:00 PM EST)

  3. Period of Performance:

    • Up to ~24 months for COGM

    • Up to ~36 months for COGM-A

Where does this funding come from?

This program is funded by the U.S. Department of Defense, administered through the Defense Health Agency (DHA) using Prototype Other Transaction Authority (10 U.S.C. §4022).

Who is eligible to apply?

To be eligible, proposals must meet at least one of the following OTA statutory conditions:

  • Include a nontraditional defense contractor or nonprofit research institution participating to a significant extent

  • All significant participants are small businesses or nontraditional defense contractors

  • At least one-third of total project cost is cost-shared by non-government sources

What companies and projects are likely to win?

Proposals are evaluated on three primary factors:

  • Strength and feasibility of the technical approach to meeting SOO requirements

  • Credibility of the management and execution plan, including regulatory and manufacturing readiness

  • Cost realism and completeness of the proposed budget

Projects starting near TRL 4 with a clear path to FDA clearance and military deployment are strongly aligned.

Are there any restrictions I should know about?

  • Proposals must comply with FDA medical device regulations

  • Foreign collaborators require additional justification

  • Participation in malign foreign talent programs is prohibited

  • Cost sharing rules apply if nontraditional or small business criteria are not met

  • Files must be submitted exactly as instructed; noncompliance may result in elimination

How long will it take me to prepare an application?

Most first-time applicants (without any assistance from BW&CO) should plan for 120–200 hours of effort over 8–12 weeks, including technical writing, budget preparation, and internal reviews.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for $13000 Initial Fee + 5% Success Fee.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Learn more about the program here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

Strengthening America’s Manufacturing and Defense Industrial Base (SAMDIB) – Cornerstone Consortium (DoD)

Deadline: Rolling Submissions until September 30, 2027

Funding Award Size: $2M to $200M

Description: DoD OTA funding for prototype projects that strengthen U.S. defense manufacturing capacity, workforce readiness, and supply chain resilience across priority industrial base sectors.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Cornerstone Consortium is accepting white papers on a rolling basis under the Strengthening America’s Manufacturing and Defense Industrial Base (SAMDIB) initiative to fund prototype projects that enhance U.S. defense manufacturing capacity, workforce resilience, and supply chain security. Awards are made via Other Transaction Agreements (OTAs) to eligible consortium members to address priority industrial base sectors supporting DoD mission readiness. White papers may be submitted anytime while the CIR is open, with evaluations conducted periodically based on Government need.

How much funding would I receive?

$2 million to $200 million. The Government does not disclose a fixed award size or total budget for this initiative but past awards reflect a range of levels from $2 million to $200 million. Funding levels vary by project scope, technical maturity, and negotiated milestones, and multiple awards may be made subject to availability of funds.

What could I use the funding for?

Cornerstone accelerates research, development, prototyping, demonstration, qualification and integration of manufacturing capabilities and capacities into the US Industrial Base and supply chains. Cornerstone integrates the diverse and currently fragmented collection of industry sectors across a range of manufacturing disciplines to ensure Industrial Base resiliency and assurance and a robust manufacturing innovation ecosystem. To this end, the technical focus of Cornerstone shall be comprised of, but not limited to, these Sector and Requirement Focus Areas:

Sector Area 1: Aircraft

Fighters, bombers, cargo, transport aircraft, combat/combat support/combat services helicopters, unmanned aircraft systems/vehicles and the associated components, equipment, networks and personnel to control unmanned aircraft.

Sector Area 2: Radar and Electronic Warfare

Semiconductor, captive monolithic microwave integrated circuits, and the related microelectronic manufacturing/assembly facilities required for continual upgrade of military radar, electronic warfare, and other related equipment.

Sector Area 3: Shipbuilding

Aircraft carriers, submarines, surface combatants, amphibious warfare, combat logistics force, and command and support vessels.

Sector Area 4: Ground Vehicles

Tactical vehicles, armored multi-purpose vehicles, and the associated products required for improvements to legacy systems such as the Bradley Fighting Vehicle, M1 series tank, High-Mobility Multi-Purpose Vehicle and Light Armored Vehicle.

Sector Area 5: Soldier Systems

Personal protective and individual systems such as clothing, boots, helmets, parachutes, chemical protective clothing, sensors and lasers, body armor, small arms, shelters, rations, clean water, laundry, and food services.

Sector Area 6: Space

Satellites, launch services, ground services, satellite components & subsystems, networks, engineering services, payloads, propulsion, and electronics.

Sector Area 7: Chemical, Biological, Radiological and Nuclear (CBRN)

Passive protection, contamination avoidance and mitigation measures taken and the applicable associated equipment used in situations where CBRN hazards may be present.

Sector Area 8: Critical Minerals & Materials

Minerals, materials, production technology, and the associated international trade supply chains that are integral to the U.S. manufacturing base and the Nation’s overall economic and national security.

Sector Area 9: Machine Tools

Machines for shaping, machining, cutting, boring, shearing, extruding, turning and the associated tools/fixtures required for holding/constraining/guiding the work piece being machined.

Sector Area 10: Cyber for the Industrial Base

A body of technologies, processes and practices designed to protect networks, computers, and programs essential to military communication and data systems from being compromised.

Sector Area 11: Optics

Enhanced night vision goggles, thermal weapons sights, monocular night vision devices, aviator’s night vision imaging systems, sniper night sights, multifunction aiming lights, mini integrated pointed illuminator modules, integrated laser white light pointers, individual and crew served weapons lights, aircrew laser pointers, green laser interdiction systems, family of weapons sights, laser target locators, lightweight laser designator rangefinders, small tactical optical rifle mounts, micro-laser rangefinders, and joint effects targeting systems.

Sector Area 12: Advanced Technology and Advanced Manufacturing

Items of equipment developed with the most advanced technology available and used by the majority of the economy. Advanced technology and advanced manufacturing advances the state of the art and, therefore, has the most growth potential.

Sector Area 13: Electronics

Consumer electronics, computers, automotive, industrial/medical equipment, telecommunications, and aero/defense. The industrial base consists of engineering companies that design integrated circuits (IC); front end companies that manufacture ICs; back end manufacturers that assemble ICs into packages; IC vendors that design and market ICs; systems integration companies that combine ICs into electronic systems; and others as applicable.

Sector Area 14: Command, Control, Communication, and Computers (C4)

Major defense acquisition programs and major automated information systems that integrate doctrine, procedures, organizational structures, personnel, equipment, facilities and communication designed to support commanders.

Sector Area 15: Munitions and Missiles

Smart bombs, tactical cruise, air-to-air, air-to-ground, and surface-to-surface missiles as well as dumb bombs, ammunition, mortars, and large caliber rounds.

Sector Area 16: Industrial Base and Manufacturing Skills

Collaborative efforts to engage the highest industrial, academic, and Government technical resources to define and address strategic manufacturing value chain vulnerabilities and program specific technical issues in support of the defense industrial base.

Sector Area 17: Trusted Capital

U.S. or NTIB Integration-partner capital. Efforts will focus on identifying relevant sources of innovation, identifying and leveraging trustworthy sources of capital, and bringing together the right sources of innovation with the right trustworthy sources of capital to accelerate financial arrangements that obviate adversary strategies.

Sector Area 18: Special Operations Forces (SOF) Operational Requirements

Capabilities that rapidly explore any relevant technologies that provide material solutions for Electronic Warfare, Intelligence/Surveillance/Reconnaissance, Computer Network Operations, C4, Weapons, Visual Augmentation Systems, Fire Support Systems, SOF Enablers, and Mobility Systems.

Are there any additional benefits I would receive?

Beyond direct nondilutive funding, Cornerstone awards offer several strategic advantages:

Government Validation and Credibility: Selection through a DoD-managed OTA consortium signals strong alignment with national defense industrial base priorities and increases trust with primes, partners, and investors.

Enhanced Visibility Across DoD: Awardees gain exposure to multiple DoD programs and stakeholders through a standing, Government-managed consortium vehicle.

Faster Contracting and Flexible Terms: OTAs allow negotiated data rights, milestone-based payments, and streamlined acquisition compared to FAR-based contracts.

Follow-On Production Potential: Successful prototype projects may be eligible for non-competitive follow-on production OTAs or transition to FAR-based production contracts, though follow-on awards are not guaranteed.

What is the timeline to apply and when would I receive funding?

White papers (15 pages) may be submitted at any time while the CIR is active. Submissions are typically evaluated within three months of receipt. If invited, full proposal timelines are set by the Government based on project complexity. Funding is received through negotiated milestone payments after OTA award.

Where does this funding come from?

Funding is provided by the U.S. Department of Defense through the Industrial Base Analysis and Sustainment (IBAS) Program and executed by Army Contracting Command – Rock Island in support of DEVCOM Chemical Biological Center.

Who is eligible to apply?

Only Cornerstone Consortium members with an executed Consortium Management Agreement, active SAM registration, and favorable responsibility status may apply. Eligible organizations include:

  • Small and large U.S. businesses

  • Non-traditional defense contractors

  • Traditional defense contractors

  • Academic institutions

  • Federally Funded Research and Development Centers

  • Private capital entities

Foreign participation is restricted and approved only on a case-by-case basis.

What companies and projects are likely to win?

Competitive selections prioritize projects that:

  • Address one or more priority industrial base sectors with clear DoD relevance

  • Demonstrate strong technical merit and feasibility

  • Strengthen domestic manufacturing capacity or supply chain resilience

  • Present reasonable cost sharing and milestone plans

  • Offer innovative or differentiated technical approaches

Are there any restrictions I should know about?

Yes. Key restrictions include limits on foreign participation, export-controlled information handling, cybersecurity compliance (NIST SP 800-171), restrictions on non-U.S. research programs, and Government Purpose Rights for technical data unless otherwise negotiated.

How long will it take me to prepare an application?

Most first-time applicants should expect 80–120 hours of effort over 8–12 weeks, including technical writing, budget preparation, and internal reviews.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for the 15 page white paper for a flat fee of $9,000. Upon invitation, full proposal is an additional $9000 + 5% Success Fee.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Learn more about the program here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

Carderock BAA - NAVY

Deadline: February 27, 2026

Funding Award Size: $500K+

Description: Funding for basic and applied research supporting Navy ship, submarine, and maritime technology priorities, including digital ecosystems, hydrodynamics, naval platform integrity, design, signature management, and unmanned systems.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The Naval Surface Warfare Center Carderock Division (NSWCCD) is soliciting proposals under its FY26 Broad Agency Announcement (BAA) for basic and applied research aligned with Navy ship, submarine, and maritime systems priorities. Awards are made as grants or cooperative agreements, with a minimum award size of $500,000 and no stated maximum. The BAA supports research across digital ecosystems, hydrodynamics, naval platform integrity, ship and submarine design, signature management, and unmanned systems. Proposals must be submitted by February 27, 2026.

How much funding would I receive?

Individual awards vary by technical scope, merit, and fund availability. The BAA lists a minimum award size of $500,000, with no stated maximum award ceiling. NSWCCD may make multiple awards, and funding levels depend on proposal quality and available funds.

What could I use the funding for?

Funding may be used for basic and applied research in the following areas:

Digital Ecosystems

  • High speed, intelligent, data-driven decision making for complex operations

  • Data discovery, information and knowledge management

  • Rapid adaptable policy and enforcement for digital environments

Hydrodynamics

  • Computational hydrodynamic tools

  • Seakeeping and loads in extreme seas

  • Maneuvering and control

  • Maneuvering in waves

  • Cavitation

  • Hull-propulsor interaction

  • Hydrodynamic modeling of operations: in an ice slurry; multi-body interactions; propulsor hull system optimization; appendage characterization and scaling; near-surface and near-shore maneuvering and control modeling development

Naval Platform Integrity

  • Naval metals and alloys; structural composites; corrosion resistant materials; and/or high-temperature ceramics

  • Manufacturing, including additive and other advanced manufacturing, and the relationship between processing, microstructure and materials properties, including Modelling & Simulation

  • Structural assessment and monitoring

  • Weapons effects and ship protection

  • Non-destructive testing and/or inspection

  • Maritime lethality

  • Structural reliability

  • Ship environmental treatment systems, management, and safety

  • Bio-fouling and bio-fouling hydrodynamic effects

  • Development of artificial intelligence and machine learning models to advance naval platform integrity

  • Battery development and safety

  • Naval platform energy and power

Ship and Submarine Design

  • Ship/Submarine design tools

  • Ship/Submarine design processes and methods

  • Design evaluation/assessment capabilities

  • New and non-traditional platforms

  • Novel ship/submarine designs and missions

Signature Management

  • Underwater and topside signatures

  • Mobile sensors

Unmanned Systems

  • Low-cost perception and situational awareness systems

  • Autonomy and AI/ML decision making and computations

  • Swarming capabilities

Are there any additional benefits I would receive?

Beyond the formal funding award, there are meaningful indirect benefits to winning a NSWCCD Carderock BAA award:

Government Validation and Credibility: Selection signals strong technical credibility and alignment with Navy and DoD research priorities, which can accelerate future partnerships and follow-on funding.

Nondilutive Technology Advancement: Funding supports research without equity dilution, allowing organizations to mature technology while preserving ownership.

Positioning for Follow-On Navy Opportunities: Successful research may inform future Navy programs, contracts, or applied development efforts.

What is the timeline to apply and when would I receive funding?

The BAA is open until February 27, 2026. Proposals may be submitted at any time before that deadline. Performance is expected to begin no earlier than three months after cost proposal submission, subject to award negotiations and fund availability.

Where does this funding come from?

Funding is provided by the Naval Surface Warfare Center Carderock Division (NSWCCD) under the Department of the Navy for basic and applied scientific research (Assistance Listing 12.300).

Who is eligible to apply?

Eligible applicants include:

  • Public and private institutions of higher education

  • Universities (including University Affiliated Research Centers, unless restricted by contract)

  • Small and large organizations

Federally Funded Research and Development Centers (FFRDCs), Navy labs, and other DoD or civilian government laboratories are not eligible as prime applicants, though teaming arrangements may be allowed.

What companies and projects are likely to win?

Proposals are evaluated using a peer or scientific review process based on:

  • Overall scientific and technical merit of the proposal

  • Importance and relevance to NSWCCD programs

  • Availability and affordability of funds

Technical merit is the most important factor, with cost realism and reasonableness also considered.

Are there any restrictions I should know about?

This BAA is for research only and not for system acquisition or operational support services. No fee or profit is allowed. Some topics may involve export-controlled technologies, limiting participation to U.S. persons under ITAR. Intellectual property assertions must be clearly disclosed, and organizational conflicts of interest must be identified and mitigated.

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive pre-proposal without assistance from BW&CO will likely take 200–250 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $15,000 + 5% Success Fee.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Read full solicitation here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

ERDC BAA - ARMY

Deadline: Rolling Deadline.

Funding Award Size: Est. $2-$10 Million

Description: Funding for research and development supporting military engineering, environmental science, infrastructure resilience, geospatial systems, computing, materials, energy, and related defense and civil works technologies.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

The U.S. Army Corps of Engineers’ Engineer Research and Development Center (ERDC) is issuing a continuously open Broad Agency Announcement to fund basic, applied, and advanced research across a wide range of engineering, environmental, and defense-relevant technology areas. Awards are made on a rolling basis through cooperative agreements, subject to the availability of funds so interested companies should submit as soon as possible.

How much funding would I receive?

ERDC does not specify a standard award size. Individual awards may range from small research efforts to very large, multi-year programs, with an overall program ceiling of $1 billion. Funding levels are determined based on technical scope, relevance, and available funding within the sponsoring ERDC laboratory.

What could I use the funding for?

To be eligible for consideration and possible contract award, the technology or methodology shall be either basic research, applied research, advanced technology development not for a specific system/hardware, or demonstration and validation.


If your technology is novel and fits into one of the following Areas of Interest, you could potentially be funded:

Coastal and Hydraulics Laboratory (CHL)

Geotechnical & Structures Laboratory (CHL)

Environmental Sensing

Contaminated Site Characterization, Assessment & Remediation

Sediment Geochemistry and Biological Effects

Environmental and Water Quality Modeling

Environmental Impact Prediction, Assessment and Management

Environmental Criteria for Stream Channel Alteration Projects

More topics in progress (see solicitation for all topics).

Are there any additional benefits I would receive?

Beyond the direct funding, ERDC awards provide meaningful strategic advantages:

Government Validation and Technical Credibility:
Selection by ERDC signals strong alignment with U.S. Army and national infrastructure priorities, which can materially strengthen your credibility with customers, primes, and investors.

Non-Dilutive Technology Maturation:
Companies can advance core technology without equity dilution, preserving ownership while increasing enterprise value.

Long-Term Government Relationship Building:
ERDC BAAs are often a gateway into follow-on DoD contracts, reimbursable work, and sole-source opportunities.

Increased Visibility Across DoD and Civil Works:
Successful projects frequently expand beyond a single lab, creating exposure across USACE, DoD, and federal infrastructure stakeholders.

What is the timeline to apply and when would I receive funding?

This BAA is continuously open until January 1, 2027, and all submissions initially enter the process as pre-proposals. Pre-proposals may be submitted at any time through the ERDCWERX portal and are limited to five pages, plus a one-page executive summary.

ERDC conducts a preliminary technical review of pre-proposals as they are received. Offerors can expect a response within 60 days of submission, either encouraging submission of a full proposal or advising that the pre-proposal was not favorably reviewed.

If a pre-proposal receives a favorable review, ERDC will issue a formal invitation from the Contracting Office to submit a full proposal. Full proposals then undergo scientific peer review, cost evaluation, and funding availability assessment.

There is no fixed award cycle or batch deadline. Awards may be made at any time following successful evaluation and are subject to availability of funds.

Where does this funding come from?

Funding is provided by the U.S. Army Corps of Engineers (USACE) through its Engineer Research and Development Center (ERDC) and supported DoD research programs.

Who is eligible to apply?

Eligibility is unrestricted, meaning any qualified U.S. or international entity may apply, subject to statutory and regulatory requirements. This includes:

  • For-profit companies

  • Startups and small businesses

  • Universities and nonprofit research organizations

What companies and projects are likely to win?

ERDC evaluates proposals based on:

  • Clear alignment with ERDC mission and stated research areas

  • Strong scientific or technical merit

  • Demonstrated capability of the proposing team

  • Practical relevance to military or civil works challenges

  • Realistic scope and cost relative to expected outcomes

Are there any restrictions I should know about?

  • ERDC may limit awards based on funding availability in specific technical areas

  • Some projects may be subject to export control, security, or publication restrictions

  • Proposals must clearly identify whether research is considered “fundamental”

  • Full proposals must be submitted only through designated laboratory channels, not directly to technical staff

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive pre-proposal under this BAA will likely take 20–40 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $4,000 for the Pre-Proposal Submission.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More
Active, specific topic Josiah Wegner Active, specific topic Josiah Wegner

Michael J Fox - Parkinson’s Disease Therapeutics Pipeline Program (TPP)

Deadline: Rolling Pre-Proposal Deadline.

Funding Award Size: $250,000 to $2,000,000+

Description: Apply for up to $5 million from The Michael J. Fox Foundation’s Parkinson’s Disease Therapeutics Pipeline Program. Funding supports preclinical, IND-enabling, and early clinical development of Parkinson’s disease therapies.

Below is a brief summary. Please check the full RFA before applying (link in resources section).

Executive Summary:

The Parkinson’s Disease Therapeutics Pipeline Program (TPP) is The Michael J. Fox Foundation’s (MJFF) flagship therapeutic development funding program designed to accelerate promising Parkinson’s disease (PD) therapies from preclinical development through early clinical proof-of-concept. The program supports both disease-modifying and symptomatic interventions and can also fund biomarker activities that directly inform therapeutic development decisions. Funding is intended to de-risk programs, generate evidence that advances key development milestones, and attract follow-on investment.

Applications begin with a rolling pre-proposal process. For the current review cycle, the application deadline is January 8, 2027 for applicants submitting pre-proposals during the period September 19 – November 27.

Companies developing differentiated Parkinson’s therapeutics with a clear path to a meaningful development milestone over the next 2–3 years should strongly consider this opportunity.

How much funding would I receive?

Funding ranges from $1M to $5M depending on development stage and project scope.

Development Stage Maximum Budget Maximum Duration

Early preclinical discovery $1M 2 years

Development candidate selection $3M 2 years

IND-enabling studies $5M 2 years

Early clinical development $5M 3 years

Final funding decisions may differ from these amounts following reviewer feedback and discussions with MJFF staff.

What could I use the funding for?

MJFF prioritizes pre-clinical and clinical programs that may slow, stop, or prevent disease progression, efforts that address moderate-to-advanced motor or non-motor symptoms of Parkinson’s not well-managed by current treatments such as advanced gait disturbances (e.g., balance issues linked to falls, freezing) and cognitive changes. Activities within scope of this program include:

• Pre-Clinical: Identifying, validating and/or developing novel pharmacological and non- pharmacological interventions through pre-clinical development from early screening topre-clinical characterization and testing.

• Clinical: Progressing promising interventions with strong preclinical packages into/through initial clinical assessment exploring pharmacokinetics and pharmacodynamics, safety/tolerability, or early proof of biology and/or clinical efficacy.For novel targets, MJFF is particularly interested in de-risking programs by supporting early proof of concept in patients to gain insight into the therapeutic potential, including exploration of biomarker-based or clinical endpoint-based efficacy.

Any intervention may be considered based on clear patient need, rationale and strong mechanism-of-action understanding. Interventions may be pharmacological (small molecules), biological (biologic, gene therapy) or non-pharmacological including surgical approaches, technology-enabled therapeutics and neuromodulation approaches. Competitive non- pharmacologic proposals will have compelling, existing data from human studies with strong potential for clinical adoption. Applicants may also propose testing of repurposed or repositioned therapies but should propose clear and robust biomarker-enabled testing strategies.

Funding supports therapeutic development activities for Parkinson’s disease across multiple stages of development. Eligible activities include:

  • Disease-modifying therapies intended to slow, stop, or prevent PD progression.

  • Symptomatic therapies intended to improve quality of life and daily functioning.

  • Small molecules, biologics, gene therapies, surgical approaches, neuromodulation approaches, and other technology-enabled therapeutics.

  • Repurposed therapies with robust biomarker-enabled and/or clinically meaningful outcome strategies.

  • Preclinical activities including hit identification, lead optimization, mechanistic studies, and clinical trial-enabling work.

  • Clinical-stage activities evaluating safety, biological activity, and early efficacy signals in people with PD.

  • Biomarker activities that support translational readiness, dose selection, patient stratification, mechanism confirmation, and other development decisions.

Are there any additional benefits I would receive?

Beyond direct funding, MJFF awards offer meaningful strategic advantages:

  • Strong Scientific and Patient-Centered Validation: Selection by MJFF signals rigorous scientific merit and strong alignment with patient-driven therapeutic priorities in Parkinson’s disease.

  • De-Risking for Follow-On Capital: MJFF explicitly positions this program to de-risk therapeutic programs and catalyze follow-on investment from venture capital, strategic partners, and other funders.

  • Access to MJFF’s Ecosystem: Awardees gain access to MJFF’s extensive network of clinicians, researchers, industry partners, patient advisors, and proprietary research tools, datasets, and biosample repositories.

  • Enhanced Exit and Commercialization Potential: Government- and foundation-validated programs often command higher valuations during licensing, acquisition, or later-stage financing due to reduced technical and clinical risk.

What is the timeline to apply and when would I receive funding?

Pre-proposals may be submitted at any time and are typically reviewed within three weeks. If invited, full proposals are submitted during one of five annual review cycles. Funding decisions are communicated within three months of full proposal submission.

Upcoming full proposal deadlines include:

  • June 25, 2026 → Funding decision September 2026

  • August 20, 2026 → Funding decision November 2026

  • October 30, 2026 → Funding decision January 2027

  • January 8, 2027 → Funding decision March 2027

Where does this funding come from?

Funding is provided directly by the Michael J. Fox Foundation for Parkinson’s Research, a nonprofit organization dedicated to accelerating cures and better treatments for Parkinson’s disease through aggressively funded translational research.

Who is eligible to apply?

Eligibility is limited to:

  • Industry applicants (biotechnology, pharmaceutical, medical device, or other for-profit companies), or

  • Academic teams partnered with an industry collaborator capable of commercial development.

Both U.S. and non-U.S. entities are eligible. The for-profit entity is expected to serve as the primary grantee and commercialization lead.

What companies and projects are likely to win?

Successful applications typically demonstrate:

  • A strong biological rationale for the therapeutic target, supported by genetic or in vitro/in vivo validation data.

  • A clearly differentiated therapeutic approach believed to be superior to existing or pipeline therapies.

  • Robust translational biomarker strategies to measure target engagement and mechanism of action.

  • Clear preclinical-to-clinical translation potential with a realistic commercialization pathway.

  • For clinical programs, a patient-centered development plan incorporating patient input.

Are there any restrictions I should know about?

MJFF will not fund:

  • Large-scale target discovery efforts (e.g., genomic or transcriptomic screening).

  • Target validation using only tool compounds with no path to drug development.

  • Reformulation of commercially available drugs via new routes of administration.

  • Studies evaluating dietary supplements.

MJFF does not intend to serve as the sole funder and expects applicants to pursue complementary funding sources.

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive pre-proposal for this opportunity will likely take 20–40 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

Additional Resources

See Request for Applications Here.

Read More
Active, Broad Topic Josiah Wegner Active, Broad Topic Josiah Wegner

Defense Sciences Office (DSO) Office-wide BAA – DARPA

Deadline: June 2, 2026

Funding Award Size: Est. $2 million

Description: Funding for revolutionary basic or applied research that advances science, devices, or systems for national security applications.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

DARPA’s Defense Sciences Office (DSO) is soliciting proposals under its Office-wide Broad Agency Announcement (BAA) to fund revolutionary basic or applied research that enables breakthrough advances in science, devices, or systems for national security applications. Proposals are accepted on a rolling basis through June 2, 2026, and may be submitted as executive summaries, abstracts, or full proposals. This BAA is designed to capture novel, high-risk, high-reward ideas not already addressed by existing DARPA programs.

How much funding would I receive?

DARPA anticipates making multiple awards, but no fixed award size or funding range is specified in the BAA. Award amounts, duration, and structure are determined based on the proposed technical scope, cost realism, and selected award instrument. An accelerated award option is available for select proposals not exceeding $2,000,000, with awards made within approximately 30 days of selection.

What could I use the funding for?

Funding may be used to pursue innovative basic or applied research concepts that enable revolutionary (not evolutionary) advances aligned with DARPA’s mission. Proposals may address, but are not limited to, the following DSO technical thrust areas:

  • Materials, Manufacturing, and Structures - Breaking the tension between performance and efficiency for critical parts, production processes, energetics, superconductors, and propulsion

  • Sensing, Measuring, and Affecting - Developing and leveraging new science to overcome existing barriers limiting the performance and/or practicality of sensing, measurement, and control, to achieve orders of-magnitude improvement in operational capabilities.

  • Math, Computation, and Processing - Enabling quantum, reimagining classical, and developing entirely new forms of computing for enhanced efficiency and new capabilities. Solutions may range from new approaches to hardware (implementation) to representation and computation.

  • Complex, Dynamic, and Intelligent Systems - Creating new scientific capabilities for classes of systems that evolve and adapt and for which traditional reductionist, data-driven, and statistical methods fail. Systems of interest include, but are not limited to, foundations of intelligence, human-AI ecosystems, homeostatic mechanisms, and global systems.

Proposals focused primarily on incremental improvements or manufacturing scale-up are explicitly excluded.

Are there any additional benefits I would receive?

Beyond direct funding, selection under a DARPA DSO BAA provides substantial indirect value:

  • DARPA Validation and Credibility: Being selected signals strong technical merit and alignment with DARPA’s mission to create or prevent technological surprise.

  • Increased Visibility: Awardees gain visibility within the national security R&D ecosystem and among DARPA program managers.

  • Access to DARPA Engagement Pathways: Participation can lead to future invitations to targeted DARPA programs, Disruption Opportunities (DOs), or Advanced Research Concepts (ARCs).

  • Nondilutive De-Risking: Advancing frontier technology with nondilutive capital can materially improve company valuation and future exit outcomes.

What is the timeline to apply and when would I receive funding?

  1. Review Process: Rolling through June 2, 2026

  2. Accelerated Award Option: Awards made within ~30 days of selection for qualifying proposals

Where does this funding come from?

Funding is provided by the Defense Advanced Research Projects Agency (DARPA) within the U.S. Department of Defense, through the Defense Sciences Office (DSO).

Who is eligible to apply?

  1. U.S. and non-U.S. organizations may apply

  2. Small businesses, startups, universities, and large firms are eligible

  3. FFRDCs, UARCs, and Government Entities (including National Labs) are not eligible

  4. Non-U.S. participants must comply with export control, security, and nondisclosure requirements

What companies and projects are likely to win?

DARPA evaluates proposals based on the following criteria:

  • Scientific and technical merit of a novel, feasible, and well-reasoned approach

  • Relevance and contribution to DARPA’s mission and national security impact

  • Clear articulation of technical risk and credible mitigation strategies

  • Strong alignment between scope, cost, and schedule realism

  • Ability to enable revolutionary—not incremental—advances

Are there any restrictions I should know about?

  • Incremental or evolutionary improvements are not of interest

  • Manufacturing scale-up is explicitly excluded

  • Some projects may involve Controlled Unclassified Information (CUI) and require compliance with NIST SP 800-171

  • Projects involving human subjects or animal research must follow DARPA approval procedures

  • DARPA retains discretion to determine whether work is fundamental or non-fundamental research

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive submission under this BAA will likely take 120–160 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $5,000 for the Abstract Submission.

Fractional support is $300 per hour, with most DARPA proposal projects requiring 80–100 hours of expert support from strategy through submission of full proposal.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More
Inactive Josiah Wegner Inactive Josiah Wegner

Generative Optogenetics - DARPA BTO

Deadline: Abstracts Due January 16, 2026 (5:00 PM ET)

Funding Award Size: $1.7M to $1.99M.

Description: DARPA’s Generative Optogenetics (GO) program funds the development of a protein complex that can be expressed in living cells and use optical signals (light) to synthesize DNA or RNA without a template. The program aims to enable massless transfer of genetic information into cells and focuses on de novo nucleic acid synthesis and optional high-fidelity error mitigation mechanisms.

Executive Summary:

DARPA’s Biological Technologies Office is awarding $1.7M–$1.99M Phase 1 awards to teams developing optically controlled, template-free DNA or RNA synthesis in living cells under the Generative Optogenetics (GO) program. The program uses a staged process beginning with 5-page abstracts due January 16, 2026, followed by invitation-only oral proposals.

How much funding would I receive?

If selected, you would receive a fixed-price Phase 1 award of $1.7M for Research Objective 1 (RO1) or $1.99M if addressing both RO1 and the optional Research Objective 2 (RO2). DARPA anticipates multiple Phase 2 awards for teams that successfully pass the Phase 1 Concept Design Review at month 9.

What could I use the funding for?

The DARPA GO program aims to develop a protein complex, referred to here as a nucleic acid compiler (NAC), that can be expressed within living cells to allow an end user to program genetic instructions into those cells, template-free, using nothing but light to transfer the genetic information to the cells (Figure 1). The central challenge of developing the NAC involves integrating protein domains / subunits for precise optical responsiveness (i.e., optogenetic domains), substrate binding, and enzymatic activity into a functional complex of proteins (i.e., a holoenzyme). While many of these domains have precedence as either engineered or naturally occurring proteins, the challenge lies in developing the interoperability and seamless integration of these domains into a functional holoenzyme, the NAC. Advances in computational design, which allow for accurate prediction of protein structures and binding interactions, are essential for optimizing substrate binding sites, allosteric interactions, and domain integration. These computational tools are crucial for designing the NAC to respond rapidly and predictably to optical signals, enabling the synthesis of long, accurate nucleic acid sequences that can precisely alter cellular function as intended. Moreover, expression of the NAC itself must not be deleterious to host cell function or viability.

To develop the NAC, the GO program consists of two Research Objectives (ROs):

Are there any additional benefits I would receive?

Beyond the direct award, companies benefit from:

DARPA Validation & Technical Credibility
Selection by DARPA’s Biological Technologies Office (BTO) signals exceptional technical rigor and alignment with DARPA’s high-risk, high-reward biotechnology priorities. This validation materially strengthens credibility with strategic partners, investors, and future government customers.

Non-Dilutive Advancement of Breakthrough Biotechnology
GO awards enable teams to mature foundational, high-risk biological technologies using non-dilutive capital. Companies can advance technically ambitious platforms without sacrificing equity, increasing both technical readiness and enterprise value.

Access to DARPA Program Leadership & Expert Networks
Awardees engage directly with DARPA program managers, technical reviewers, and advisory working groups throughout the program. This access provides rare insight into government priorities, technical expectations, and future transition considerations.

Commercialization Support & Structured Market Exposure
GO performers receive guidance from an Independent Commercialization and Consulting Group (ICCG) and participate in structured commercialization workshops and pitch events. These activities help teams refine business hypotheses, market positioning, and transition strategies alongside experienced investors and operators.

Enhanced Visibility Across the Biotechnology Ecosystem
Participation in a DARPA flagship biology program elevates company visibility across the defense, academic, and commercial biotech ecosystems—positioning awardees as leaders in next-generation genetic and optogenetic technologies.

Stronger Long-Term Exit & Transition Potential
By maturing core technology under DARPA sponsorship and demonstrating government-backed technical progress, companies strengthen their positioning for follow-on funding, strategic partnerships, and long-term acquisition or licensing opportunities.

What is the timeline to apply and when would I receive funding?

The process begins with a 5-page abstract due January 16, 2026.. Selected teams are invited to present an in-person Oral Proposal Package. Phase 1 awards follow oral presentations, subject to funding availability. Phase 1 runs 12 months, with a major down-selection at month 9. Phase 2, if awarded, runs an additional 30 months

Where does this funding come from?

Funding is provided by the Defense Advanced Research Projects Agency (DARPA) within the Department of Defense, through DARPA’s Biological Technologies Office (BTO), using Other Transaction (OT) for Prototype authority.

Who is eligible to apply?

Eligible applicants include U.S. and non-U.S. companies, startups, universities, nonprofits, and research institutions, including nontraditional defense contractors and small businesses. Federally Funded Research and Development Centers (FFRDCs) and government entities may apply with additional eligibility documentation. All performers must be able to accept an OT agreement and comply with export control and CUI requirements.

What companies and projects are likely to win?

Competitive teams will demonstrate deep expertise in protein engineering, optogenetics, enzymatic nucleic acid synthesis, and computational biology, with a credible plan to integrate these into a functioning system in living cells. DARPA emphasizes technically bold, high-risk approaches that directly address program metrics rather than incremental biology research.

Are there any restrictions I should know about?

Yes. The program excludes human and animal research, embryonic stem cells, bioprospecting for new natural proteins, substantial hardware development, in vitro assembly workflows, and systems that operate outside the central dogma. Phase 2 work involves Controlled Unclassified Information (CUI), requiring NIST 800-171–compliant systems and DARPA security coordination.

How long will it take me to prepare an application?

Most teams should expect 4–6 weeks to prepare a competitive abstract, including technical framing, team formation, and compliance review. Invited teams will need additional time to prepare a detailed Oral Proposal Package, cost models, and milestone plans under DARPA’s OT structure

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

$4,000 for Abstract Submission.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More
Inactive Josiah Wegner Inactive Josiah Wegner

Space Domain Awareness Solutions CSO

Deadline: White Paper Close Date: January 20, 2026

Funding Award Size: $300K-$1.5M

Description: The U.S. Space Force is soliciting innovative commercial solutions to enhance Space Domain Awareness (SDA) through advanced software, data analytics, modeling, and R&D-focused prototyping. This CSO enables rapid acquisition of commercial technologies that improve detection, characterization, prediction, and analysis of activities in the space domain.

Executive Summary:

The U.S. Space Force Space Acquisition & Integration Office (SAIO) is awarding up to $6 million through a multi-year Commercial Solutions Opening (CSO) to small businesses developing innovative Space Domain Awareness (SDA) solutions. Companies submit short white papers under specific Areas of Interest (AOIs), with AOI-2025_01 closing January 20, 2026.

How much funding would I receive?

Funding amounts are determined at the AOI and proposal level. For AOI-2025_01, awards are expected to come from a shared ~$1.5M funding pool across multiple AOIs. The Government may fund all, some, or part of a proposed solution, depending on mission priority, technical merit, and available funds.

What could I use the funding for?

SpOC/S33Z – SDA Capability Enhancement seeks research, development, and prototyping efforts that advance state-of-the-art methods for managing, analyzing, and exploiting space sensor data. The dynamic and challenging SDA environment requires novel approaches that go beyond traditional software development, with emphasis on experimental techniques, proof-of-concept demonstrations, and technology maturation that can transition into operational use.

Technical Focus Areas (TFAs)

Offerors may propose solutions aligned with one or more of the following TFAs. All submissions should emphasize the R&D aspect of their approach, with deliverables expected to include prototypes, models, and/or experimental frameworks rather than production-ready systems.

Are there any additional benefits I would receive?

Beyond the direct award, companies benefit from:

Government Validation & Technical Credibility
Being selected by the U.S. Space Force Space Acquisition & Integration Office (SAIO) signals strong technical credibility and alignment with Space Domain Awareness (SDA) mission priorities—significantly strengthening trust with primes, integrators, and future DoD customers.

Non-Dilutive Technology Maturation
CSO awards enable companies to advance high-risk, high-impact SDA software and analytics technologies using non-dilutive capital, preserving founder equity while increasing enterprise value and technical maturity.

Access to Space Force Operational Stakeholders
Awardees gain direct exposure to Space Force operators, technical leads, and acquisition personnel within the SDA enterprise—creating opportunities for transition paths, follow-on AOIs, and future operational adoption.

Increased Visibility & Notoriety
Participation in Space Force–funded R&D enhances visibility across the national security space ecosystem, including government stakeholders, defense primes, and the broader space technology community.

Strengthened Exit / Acquisition Potential
Demonstrating government-backed progress in SDA capabilities positions companies for strategic partnerships, follow-on contracts, or acquisition by major defense and space industry primes.

What is the timeline to apply and when would I receive funding?

Phase I submissions consist of a white paper and short PowerPoint briefing. For AOI-2025_01, white papers close January 20, 2026. Selected companies may be invited to pitch sessions and then submit a full proposal. Award notifications typically occur within ~45 days of evaluation, with contract start dates generally ~90 days after final proposal submission.

Where does this funding come from?

This funding is provided by the U.S. Space Force, administered through the Space Acquisition & Integration Office (SAIO) under DFARS 212.70 Commercial Solutions Opening authority.

Who is eligible to apply?

Eligibility is limited to U.S. entities. AOI-2025_01 is a 100% small business set-aside under NAICS 541715. Offerors must comply with NIST SP 800-171 cybersecurity requirements and be eligible for federal contracting.

What companies and projects are likely to win?

Winning teams are typically small businesses with strong technical depth in space data, analytics, modeling, or software R&D, and a clear understanding of SDA mission needs. Competitive proposals emphasize innovation, feasibility, and operational relevance, while remaining realistic in scope, schedule, and cost.

Are there any restrictions I should know about?

Phase I submissions must be unclassified. Foreign participation is prohibited due to export control and national security restrictions. The Government will acquire only minimum necessary data rights, allowing companies to retain ownership of their core IP.

How long will it take me to prepare an application?

Most teams should expect 4–6 weeks to prepare a compliant Phase I submission, including the quad chart, PowerPoint briefing, and white paper. Founders should plan additional time if cybersecurity documentation or internal technical alignment is needed.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More
Broad Topic Josiah Wegner Broad Topic Josiah Wegner

Emerging Weapons, Munitions Systems, and Soldier Lethality BAA

Deadline: Just Extended to March 17, 2026.

Funding Award Size: Est. $1 to $10 million

Description: This BAA funds new, innovative research concepts that advance the state of the art across the full spectrum of Army armaments, munitions, fire control, autonomy, energetics, advanced materials, soldier lethality, logistics, AI/ML, sensors, and related technologies. Proposed efforts must be scientific studies or experimentation that increase knowledge within the DEVCOM Armaments Center technical community.

Executive Summary:

The U.S. Army’s Emerging Weapons and Munitions Systems & Soldier Lethality BAA invites industry and academia to submit innovative R&D concepts that advance a wide variety of critical armament technologies. The program remains open through March 17, 2026, and white papers may be submitted at any time.

How much funding would I receive?

The BAA does not specify individual award ceilings. Awards may be:

  • Contracts for basic/applied research

  • Other Transactions for Research or Prototypes (including cost-share requirements in some cases)

  • Multi-year efforts, typically up to three years, with incremental funding.

The scope and cost depend entirely on the proposed technical approach and feasibility.

What could I use the funding for?

The U.S. Army Futures Command’s Army Modernization Strategy (AMS) will catapult the U.S. Army forward to meet its enduring responsibility as part of the Joint Force to provide for the defense of the United States, and retain and secure its position by 2035 as the globally dominant land power. The end state is a modernized Army capable of conducting Multi-Domain Operations (MDO) as part of an integrated Joint Force in a single theater. The MDO concept describes how the Army will support the Joint Force in the rapid and continuous integration of all domains of warfare – land, sea, air, space, and cyberspace – to deter and prevail as we compete short of conflict, and fight and win if deterrence fails.

The modernization strategy shifts the top focus to mid-term modernization, while maintaining readiness for current operations. The six Army modernization priorities – long range precision fires, next generation combat vehicles, future vertical lift, network, air and missile defense, and soldier lethality are the pillars of our future success. Additionally, the Army will continue to reform its business processes, shifting from Industrial Age to Information Age approaches.

It is anticipated that many future technology developments will be made in conjunction with the tools of the Information Age. Modeling and Simulation (M&S) is considered as a key tool needed to bring next-generation technology to the warfighter on time, and at minimal costs.

M&S should be incorporated into technology developmental efforts whenever possible. Additionally, it is believed that concepts like the Containerized Software Applications & Orchestration, DevSecOps, Government Cloud Software Factories, Internet of Things (IOT), Artificial Intelligence (AI) and Cyber Security (CS) will play increasingly more prominent roles in many of the technologies that will be developed to provide the battlefield overmatch that we need, and to keep our warfighter safe.

The U.S. Army Armaments Center’s Business Interface Office is looking to identify and develop technologies for the purpose of addressing key elements of the Army’s modernization priorities. Efforts under this BAA should focus on the development and demonstration of technology for current and future generation munitions and armament systems, including Logistics. This shall be accomplished via investigative research efforts in the following general technology areas:

Are there any additional benefits I would receive?

Beyond the direct award, companies benefit from:

Government Validation & Technical Credibility
Being selected by DEVCOM Armaments Center signals that your technology aligns with Army modernization priorities—significantly strengthening credibility with primes, integrators, and investors.

Non-Dilutive Technology Maturation
Awards allow companies to advance high-risk, high-impact technologies with non-dilutive capital, increasing enterprise valuation and accelerating commercialization.

Access to Army Technical Stakeholders
Awardees collaborate with government engineers, program offices, and test facilities—creating opportunities for future transition paths, follow-on funding, and insertion into Army programs of record.

Increased Visibility & Notoriety
Participation in Army-funded R&D often enhances visibility with Congress, DoD stakeholders, and defense industry partners.

Strengthened Exit / Acquisition Potential
Demonstrating government-backed R&D progress increases the likelihood of strategic partnerships or acquisition by major defense primes.

What is the timeline to apply and when would I receive funding?

  • BAA Open Period: Open until Mar 17, 2026.

  • White Papers: May be submitted any time during the open period.

  • Evaluation: Approximately 3 weeks after submission.

  • Proposal Requests: Only if the white paper is rated Promising, though any offeror may voluntarily submit a full proposal.

  • Awards: Rolling, contingent on available funding; multi-month contracting timelines should be expected.

Because the BAA is continuously open, funding timing varies but generally follows white paper evaluation → proposal submission → negotiation → award.

Where does this funding come from?

Funding is provided by the U.S. Army Combat Capabilities Development Command (DEVCOM) Armaments Center, located at Picatinny Arsenal, under federal R&D authority including FAR 6.102(d)(2), 10 U.S.C. 2371/2358 (Other Transactions), and applicable DoD research statutes.

Who is eligible to apply?

All responsible sources may apply, including:

  • Traditional and nontraditional defense contractors

  • Small and large businesses

  • Universities and research institutions

  • Nonprofits

The BAA encourages participation from HBCUs and Minority Institutions.

SAM.gov registration is required prior to award. White papers and proposals must be submitted via email to the contracting POCs.

What companies and projects are likely to win?

Highly competitive proposals will:

  • Directly address one of the 28 detailed technology areas (e.g., advanced materials, energetics, AI/ML, fire control, autonomous munitions, logistics, digital engineering).

  • Provide innovative, non-incremental research concepts

  • Demonstrate feasibility, technical merit, and Army relevance

  • Show strong organizational capability, facilities, and past performance

  • Include clear pathways to future Army integration

Funded efforts typically target high-impact, dual-use, defense-relevant technologies aligned to Army modernization priorities such as long-range precision fires, soldier lethality, next-generation combat systems, and advanced energetics.

Are there any restrictions I should know about?

Key restrictions include:

  • Some OT awards may require cost share (e.g., 50/50 for research TIAs).

  • Classified submissions require prior approval and special handling.

  • Possession of a SECRET facility clearance is recommended for potential future phases (not needed to get started).

How long will it take me to prepare an application?

Typical preparation timelines:

  • White Paper: 2–6 weeks depending on complexity.

  • Full Proposal (if requested): 6–12+ weeks for technical, cost, and contractual documentation.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available to submit a white paper for a flat fee of $4,000.

Fractional support is $300 per hour, with most scout card projects requiring 10-12 hours of work.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More
Broad Topic Josiah Wegner Broad Topic Josiah Wegner

Drone Dominance Program (DDP) – One-Way Attack (OWA) sUAS Procurement

Deadline: The Request for Solutions (RFS) is expected December 17, 2025 with Gauntlet I beginning February 17, 2026 (est.). This is a multi-phase program running through January 2028.

Funding Award Size: $5 Million+

Description: The Department of War’s Drone Dominance Program seeks low-cost, U.S.-made small unmanned aerial systems (sUAS) capable of One-Way Attack (OWA) missions. The program aims to rapidly scale American industrial capacity to produce cheap, attritable, combat-ready drones at volume. Companies compete in Gauntlet field events, and high-scoring systems receive fixed-price production orders.

Executive Summary:

The Department of War’s Drone Dominance Program (DDP) will award up to $1 billion in fixed-price orders for companies that can design and manufacture low-cost, NDAA-compliant, One-Way-Attack sUAS at scale. Up to 25 vendors will be invited to Gauntlet I, with winners receiving production orders of at least 1,000 units. The RFS is expected December 17, 2025, and Gauntlet I begins February 2026.

How much funding would I receive?

Awards are fixed-price production orders—no development funding, no cost reimbursement, and no progress payments. Vendors are paid only for accepted units delivered. Planned procurement (page 1 table):

  • 30,000 units in Phase I ($150M total)

  • 60,000 units in Phase II ($300M total)

  • 100,000 units in Phase III ($300M total)

  • 150,000 units in Phase IV ($345M total)

Up to 12 vendors in Phase I will receive orders, with minimum buys of 1,000 units per vendor. Larger orders go to top performers.

What could I use the funding for?

Funding is strictly for production and delivery of compliant, mission-ready low-cost, NDAA-compliant, One-Way-Attack sUAS.

Are there any additional benefits I would receive?

Beyond the production revenue, awardees stand to gain substantial strategic advantages:

Government Validation & Competitive Differentiation
Being selected through Gauntlet scoring—publicly posted via leaderboard—serves as strong validation of performance, reliability, and manufacturing scale. This credibility improves trust with primes, integrators, and future government buyers.

Accelerated Market Visibility
Winners enter widely publicized Gauntlet announcements and procurement cycles. The DoW expects increasing visibility across phases as the program scales toward 200,000+ drones purchased by 2027.

Commercial & Dual-Use Positioning
A proven low-cost, high-reliability sUAS platform creates runway for commercial security, inspection, and tactical robotics markets.

Stronger Exit and Investment Potential
Demonstrating performance at scale via nondilutive production orders increases valuation, derisks manufacturing capability, and strengthens attractiveness for acquisition by defense primes, autonomy companies, and major drone manufacturers.

What is the timeline to apply and when would I receive funding?

  • RFS Release: ~December 17, 2025

  • Selections Notified: Week of January 26, 2026

  • Gauntlet I: Begins February 17, 2026 (est.)

  • Deliveries: Two tranches each phase, due 2.5 and 4.5 months after Gauntlet

Production payments occur upon delivery and acceptance of units.

Where does this funding come from?

The Department of War will issue orders using 10 U.S.C. 4022 Other Transaction Authority, executed through the S2MARTS OTA consortium. The program intends to place up to $1B in fixed-price orders over four phases.

Who is eligible to apply?

Per the program FAQ and RFI:

  • Eligible: Companies from the United States and allied Five Eyes nations

  • Strong Preference: U.S. companies manufacturing in the U.S. with American-made components and materials

  • Systems must be NDAA-compliant (no covered foreign components).

What companies and projects are likely to win?

Winners will be companies that can deliver:

  • Low-cost, attritable sUAS that meet OWA mission requirements

  • 10 km strike range (open terrain) & 1 km (urban) with 2kg payload

  • High reliability and ease of use, with only ~2 hours of operator training needed

  • NDAA-compliant supply chains

  • Production scaling capability into tens of thousands of units per phase

  • Fast delivery under tight 2.5–4.5 month timelines

  • Supply-chain secure manufacturing beyond minimum NDAA rules

Systems must withstand increasingly complex Counter-UAS environments in later phases.

Are there any restrictions I should know about?

Yes:

  • No progress payments; no cost reimbursement—vendors carry all development risk

  • No classified submissions

  • NDAA compliance required

  • Foreign components from covered countries are prohibited

  • All submissions must be made through the NSTXL standardized form

  • Vendors must meet requirements of 10 USC 4022(d)

  • Vendors are limited to fixed-price production only—no R&D funding

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive proposal will likely take 50-100 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee + success fee (Pricing available upon request).

Fractional support is $300 per hour, with most scout card projects requiring 10-12 hours of work.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See RFI on Sam.Gov

Read More
Broad Topic Josiah Wegner Broad Topic Josiah Wegner

Army Medical Operational Capabilities for 2040 BAA

Deadline: Rolling Deadline Until 12/31/2030

Funding Award Size: Est. $2 to $5 million

Description: The U.S. Army Medical Capability Development Integration Directorate (MED CDID) is seeking innovative concepts, technologies, and solutions that enable tactical-level Army medical units (Corps and below) to clear the battlefield, maximize return to duty, and overcome contested medical logistics in the 2040 Future Operational Environment. Solutions may address evacuation, prolonged care, diagnostics, advanced therapeutics, predictive and autonomous logistics, and cross-cutting enablers like AI/ML, human-machine teaming, and medical modeling and simulation

Executive Summary:

The MED CDID Broad Agency Announcement (BAA) invites industry and other performers to propose innovative medical concepts and technologies that support tactical Army medical units in the 2040 Future Operational Environment. The program is open through December 31, 2030, using a multi-step process: submission of a Vulcan Scout Card, followed—if selected for further interest—by a white paper and then a full technical and cost proposal. Companies should plan their internal timelines to first shape a high-impact Scout Card aligned to MED CDID’s three imperatives: clearing the battlefield, maximizing return to duty, and overcoming contested logistics.

How much funding would I receive?

The MED CDID BAA does not specify individual award ceilings or a total program funding limit. Instead, offerors must propose a Rough Order of Magnitude (ROM) total cost (including any fee) that is consistent with the scope of work, period of performance, and any dollar ranges specified in the announcement or follow-on calls. Common costs range from $500K to $5M.

What could I use the funding for?

Proposals should address at least one problem associated with the following aspects of the future operational environment (FOE):


a. Enemy action (through fires, maneuver, electronic warfare, etc.) will inhibit evacuation and medical resupply operations. Slow, reduced, or ineffective evacuation or medical resupply delays the Soldier’s treatment at the proper medical treatment facility. When evacuation slows, the consumption of medical treatment items increases, thus compounding the resupply problem. The cumulative effects of inadequate evacuation and medical resupply will reduce the return to duty rate and increase the number of preventable deaths.

b. The proliferation of drones, sensors, and other advanced technologies has made the modern battlefield more transparent than ever before. This transparency, coupled with long range precision and massed fires, requires Army forces to be distributed across a wider area and to displace frequently. Enemy precision and massed fires will result in more frequent mass casualty incidents, which will likely occur in support areas rather than near the front lines. Future medical forces must therefore be highly mobile to conduct survivability moves, to support widely distributed units, and to respond quickly to the point of need with both medical personnel and supplies (Class VIII).

c. The future battlefield will likely have a broad range of man-made and naturally occurring chemical and biological threats. These threats may be varied and difficult to detect and prevent, making early warning systems crucial. Toxic industrial chemicals and toxic industrial materials in urban areas pose additional threats. Directed energy and other new weapons may cause novel wound patterns that require new training and treatments.

d. When operating in urban areas, challenges include moving through routes blocked by rubble, craters, and other obstacles. Medical units must plan to extract patients from collapsed buildings, interaction with civil medical infrastructure, and potentially large numbers of injured civilians and enemy prisoners.

e. An increasingly transparent and lethal battlefield with chem-bio threats and new weapons systems will create continuous physiological and psychological stressors. These stressors will lead to a decline in the cognitive, physical, and emotional aspects of Soldier performance, and thus a decline in unit combat effectiveness. Army medical units must expand capacity to build and restore individual resiliency, to reduce disease non-battle injury (DNBI) losses, and increase return to duty (RTD).

AREAS OF INTEREST

The Army is looking for solutions in the following categories. Please note that these categories are not comprehensive, but rather to provide context. Categories may be created or removed as time progresses:

Are there any additional benefits I would receive?

Beyond the direct award, MED CDID funding offers significant strategic advantages for companies operating in defense, medical technology, logistics, AI/ML, and dual-use innovation:

Government Validation and Credibility:
Being selected by the U.S. Army Medical Capability Development Integration Directorate demonstrates strong technical merit and alignment with Army 2040 operational needs. This validation can accelerate engagement with primes, program offices, integrators, and investors who prioritize government-vetted technologies.

Enhanced Visibility and Notoriety:
Although the BAA does not explicitly promise publicity, MED CDID-aligned innovations often surface in Army medical modernization discussions, technical exchanges, and defense-sector forums—raising your company’s profile across DoD medical, logistics, and capability development communities.

Ecosystem Access and Collaboration Opportunities:
Awardees gain direct interaction with MED CDID, Army Futures Command stakeholders, and operational medical units. These touchpoints can open pathways to experimentation events, requirements discussions, field evaluations, and future contracting opportunities with Army, Joint, and SOF medical acquisition organizations.

Stronger Exit and Acquisition Potential:
Nondilutive DoD funding that advances medical, logistics, or autonomy technologies—combined with Army validation—typically increases a company’s valuation and attractiveness to acquirers in defense, biotech, medtech, autonomy, and advanced manufacturing. Government-backed maturity substantially strengthens both commercial and dual-use exit potential.

What is the timeline to apply and when would I receive funding?

Open period: The announcement is open from its posting date through December 31, 2030, as an open-ended BAA.

  • Submission cadence: Vulcan Scout Cards may be submitted at any time during the open period, subject to the process in the BAA. The government may also issue separate, focused calls for follow-on white papers at any time while the BAA is active.

  • Multi-step process:

    1. Vulcan Scout Card submission.

    2. If of interest, MED CDID may request a white paper and/or

    3. A formal technical and cost proposal.

The BAA does not specify review cycle timing or when funds would be awarded after a proposal is submitted. Actual award timing will depend on when MED CDID issues a request for proposal, internal evaluations, and contracting timelines.

Where does this funding come from?

This opportunity is issued by the U.S. Army Medical Capability Development Integration Directorate (MED CDID), which is responsible for enabling the Army Health System and developing future medical concepts and requirements for the Army and Joint Force

Who is eligible to apply?

The BAA does not restrict eligibility. Typical BAAs accept proposals from:

  • U.S. businesses of any size

  • Universities

  • Nonprofits

  • Federally-funded research and development centers (with limitations)

Foreign entities may be subject to additional restrictions depending on classification and export-control considerations.

What companies and projects are likely to win?

Based on the BAA’s emphasis, competitive projects are likely to:

  • Directly address one or more of the three MED CDID imperatives:

    • Clearing the battlefield (evacuation, prolonged care, integrated patient-movement C2).

    • Maximizing return to duty (resiliency, OPH, advanced diagnostics and treatment, training).

    • Overcoming contested logistics (advanced manufacturing, predictive MEDLOG, multimodal resupply).

  • Provide innovative, future-oriented solutions for the 2040 operational environment, not just incremental improvements to current practice.

  • Show clear relevance to the described FOE challenges (distributed forces, mass casualties, CBRN threats, urban operations, contested logistics).

  • Leverage cross-cutting enablers such as AI/ML, human-machine teaming, interoperability with joint and allied forces, and medical modeling and simulation to materially improve outcomes (reduced preventable deaths, higher RTD rates, more resilient logistics).

In short, teams that tightly map their concept to these problem statements and demonstrate operational impact for Corps-and-below medical units are best aligned with the BAA.

Are there any restrictions I should know about?

  • Tactical level focus: The BAA is focused on tactical-level (Army Corps and below) medical units, not broader health systems in isolation.

  • Targeted white papers: White papers should address only the specific portion of the BAA the offeror intends to accomplish. Submitting a single white paper that tries to cover the entire scope of the BAA is “most likely” to be rejected.

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive scout card under this BAA will likely take 20–30 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available to submit a scout card for a flat fee of $2,500.

Fractional support is $300 per hour, with most scout card projects requiring 10-12 hours of work.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on Vulcan

Read More
Inactive Josiah Wegner Inactive Josiah Wegner

DLA Military Unique Sustainment Technology III (MUST-III) Broad Agency Announcement (BAA)

Deadline: January 16,, 2026.

Funding Award Size: Likely $5M to $10M+

Description: The MUST-III program funds R&D projects that modernize the Department of Defense clothing and individual equipment (CIE) supply chain—advancing digital manufacturing, supply chain resilience, and innovation in textile technologies to support rapid, scalable, and cost-effective military sustainment.

Executive Summary:

The Defense Logistics Agency’s MUST-III BAA provides up to $50M over five years for R&D that improves the military’s clothing and equipment manufacturing ecosystem. Companies may apply during the initial 45-day window (through Jan 16, 2026) for IDIQ consideration, or later through rolling White Paper submissions once the BAA reopens.

How much funding would I receive?

The BAA does not specify individual award ceilings, but it does specify:

  • Total available program funding: up to $50M over 5 years.

  • Awards are issued as cost-type contracts, which commonly support multi-hundred-thousand- to multi-million-dollar R&D projects.

  • Each Short-Term Project (STP) is typically 3–24 months.

Historically, DLA ManTech STPs are substantial technical efforts—often sized to fully execute a discrete R&D solution (e.g., digital thread capability, manufacturing prototype, supply chain modeling tool).

What could I use the funding for?

Projects must align with one of the three Technical Areas of Interest:

Are there any additional benefits I would receive?

Beyond direct funding, companies gain several strategic advantages:

Government Validation & Credibility
Selection under DLA’s Manufacturing Technology (ManTech) program is a strong technical endorsement. This validation can accelerate partnerships with primes, OEMs, and investors who trust government-vetted innovation.

Visibility & Industry Notoriety
Awardees participate in DLA working groups and may be highlighted in federal program materials—raising national profile within the defense textile and advanced manufacturing ecosystem.

Access to DLA Experts & Ecosystem Collaboration
IDIQ awardees join a 5-year Working Group, providing direct collaboration with DLA program managers, CIE stakeholders, and other innovators—unlocking future contracting and transition opportunities.

Stronger Long-Term Valuation & Exit Potential
Advancing technology under nondilutive federal funding de-risks the product roadmap and strengthens valuation in future equity rounds or acquisition discussions—especially with defense, apparel manufacturing, or automation companies.

What is the timeline to apply and when would I receive funding?

Initial Deadline:

  • Full technical & cost proposals due January 16, 2026 (45 days after Dec 2, 2025 posting).

  • These proposals are for IDIQ contract consideration.

After Initial Period:

  • The BAA temporarily closes for evaluation.

  • It then reopens for rolling White Paper submissions for the remainder of the 5-year period.

Award Timing:

  • After evaluation, DLA notifies offerors of selection.

  • Task orders (STPs) may or may not be immediately issued to IDIQ holders.

  • Additional STPs may be awarded after White Papers → requested proposals → evaluation cycle.

Where does this funding come from?

Funding comes from the Defense Logistics Agency (DLA) under the Department of Defense (DoD) Manufacturing Technology (ManTech) Program.

Who is eligible to apply?

Any responsible U.S. source capable of meeting government requirements, including:

  • Large businesses

  • Small businesses (including WOSB, HUBZone, SDB, VOSB, SDVOSB)

  • Nonprofits

  • Universities / Minority Institutions

  • HBCUs

There is no set-aside.
Must meet minimum standards in: financial resources, accounting system adequacy, technical capabilities, past performance, and compliance with FAR Part 9.

What companies and projects are likely to win?

Competitive applicants typically include companies with:

  • Expertise in digital engineering, textile manufacturing, AI/ML, automation, or supply chain analytics.

  • Demonstrated DoD or CIE manufacturing experience (digital data, prototyping, supply chain modeling).

  • Capabilities aligned tightly to Technical Areas of Interest.

  • Strong past performance and ability to transition solutions into the production environment.

Examples of strong project types:

  • Digital twin implementation for apparel manufacturing

  • Secure digital technical data environment (authoritative source of truth)

  • Surge production capability modeling

  • Automated sewing or 3D knitting demonstrations

  • Wearable sensor textiles

  • AI-enabled supply chain forecasting for CIE items

Are there any restrictions I should know about?

Key requirements include:

  • Cybersecurity compliance (DFARS 252.204-7012, NIST SP 800-171, CMMC).

  • No compensation for proposing STPs (including White Papers).

  • Subcontracting plans required for large businesses on proposals > $750,000.

  • Projects must be executed within U.S. regulations for export controls, IP, and data rights.

How long will it take me to prepare an application?

For a first-time applicant, preparing a full proposal under this opportunity will likely take 150-200 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $15,000 + a 5% Success Fee.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Resources

See the full solicitation here.

Read More
specific topic Josiah Wegner specific topic Josiah Wegner

ARPA-H BioStabilization Systems (BoSS)

Deadline: February 19, 2026.

Funding Award Size: Likely $10M+

Description: ARPA-H’s BoSS program funds breakthrough technologies that stabilize, manufacture, and distribute live cell-based therapies at ambient temperatures—eliminating the need for ultra-cold storage. Selected teams will build a scalable bioprocessing platform capable of producing thermally stable cells for biologics, gene and cell therapies, regenerative medicine, biosurveillance, blood products, and large-scale genetic testing.

Executive Summary:

The ARPA-H BioStabilization Systems (BoSS) program provides multi-year support for teams developing ambient-temperature cell stabilization and scalable bioprocessing systems. Performer Solution Summaries are due February 19, 2026.

How much funding would I receive?

ARPA-H anticipates multiple OT awards, with the expectation that Performer teams will be funded through multi-phase development (up to 48 months). While specific award ceilings aren't stated, ARPA-H OT programs typically support multi-million-dollar development efforts and note that several teams may be funded initially with down-selects in later phases.

What could I use the funding for?

The BioStabilization Systems (BoSS) program aims to transform how live cell-based therapies are stabilized, manufactured, and distributed. At its core, BoSS addresses a foundational bottleneck in the delivery of advanced cell and gene therapies (CGTs): the critical dependence on ultra-cold conditions (-80 to -196˚C) for storage and transport. BoSS will yield a bioprocessing system that enables scalable production of thermally stable cells, paving the way for a new era of efficient and resilient manufacturing and distribution of biologics without any need for cold storage. BoSS-developed technologies will also accelerate many other avenues in biotechnology that directly impact healthcare, including bio-surveillance, regenerative medicine, large-scale genetic testing, blood product supply, and wound repair, in addition to improving access to a wide range of existing biotherapeutics.

This ISO is intended to solicit:

1) Performer teams that can pioneer breakthrough cell stabilization technologies and integrate these technologies into a commercially viable system for producing cell therapy products at scale. Strategic partnerships are encouraged to best position technologies for commercialization success, such as assembling multidisciplinary teams that may include experts from academic, industry, regulatory, commercialization, and non-traditional backgrounds.

2) An Independent Verification and Validation (IV&V) partner to reliably provide well-characterized, clinically relevant, government-selected cells to Technical Area Performers. This partner will also assess cell viability and system performance at critical junctures throughout the program.

Are there any additional benefits I would receive?

Beyond the primary funding, BoSS awardees gain several indirect strategic advantages:

Government Validation & Credibility
Selection by ARPA-H establishes strong scientific legitimacy and positions your technology as a potential national-level biomanufacturing platform.

Enhanced Visibility & Notoriety
Awardees are featured through ARPA-H communications, Proposers’ Day events, and industry engagement, increasing recognition among biotech investors, health systems, and biopharma manufacturers.

Access to a National Innovation Network
BoSS includes structured engagement with an Independent Verification & Validation (IV&V) partner, FDA interactions, and optional commercialization support—creating opportunities for partnerships, pilot studies, and eventual technology adoption.

Stronger Exit, Growth, and Acquisition Potential
Nondilutive development of platform technologies can significantly improve valuation, especially for companies working in CGT manufacturing, biosurveillance platforms, or enabling bioprocessing technologies. Government validation reduces perceived technical risk for acquirers and later-stage investors.

What is the timeline to apply and when would I receive funding?

Key dates:

  • Proposers’ Day: January 29, 2026

  • Performer Solution Summary: February 19, 2026

  • Performer Pitch: March 26, 2026

  • IV&V Solution Summary: April 17, 2026

  • IV&V Pitch: May 15, 2026

Where does this funding come from?

Funding is issued through the Advanced Research Projects Agency for Health (ARPA-H), under the Scalable Solutions Office, using Other Transaction (OT) authority for high-risk, high-impact biomedical innovation.

Who is eligible to apply?

Universities, Nonprofits, Small and large commercial businesses, Non-U.S. entities (with restrictions; must not be from foreign entities of concern), Must conduct work in the U.S., FFRDCs and U.S. Government entities cannot participate as Performers.

What companies and projects are likely to win?

See full solicitation for details. Strong candidates include companies with capabilities in:

  • Cell & gene therapy engineering

  • Bioprocessing & biomanufacturing instrumentation

  • Biomaterials, polymers, encapsulation, or intracellular protectants

  • Cell preservation technologies (cryopreservation alternatives, desiccation biology)

  • Microfluidics, closed-system processing, or continuous manufacturing

  • Regulatory-ready biologics or device development expertise

  • Advanced analytical platforms (cell viability, potency, functional assays)

Winning projects will propose integrated TA1 + TA2 solutions capable of achieving:

  • Room-temperature stability (14 days → 3 months)

  • Reanimation <1 hour by Phase 3

  • High viability, function, and potency metrics across multiple cell types

Are there any restrictions I should know about?

Key restrictions include:

  • No genetic manipulation of cells

  • No dangerous gain-of-function research (per EO 14292)

  • No demonstrations on RBCs or microbial species

  • No slow (>4 hr prep or >1 day processing) methods

  • No methods that cannot scale or meet GMP requirements

  • No traditional lyophilization

  • Teams must maintain SAM.gov registration for Step 2

How long will it take me to prepare an application?

For a first-time applicant, preparing a solution summary under this opportunity will likely take 50-70 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $4,000 to submit a solution summary.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Resources

See the full solicitation here.

Read More
Broad Topic Josiah Wegner Broad Topic Josiah Wegner

DARPA Information Innovation Office (I2O) Broad Agency Announcement (BAA)

Deadline: Rolling Deadline Until 11/1/26

Funding Award Size: Est. $2 million

Description: DARPA’s Information Innovation Office (I2O) is soliciting revolutionary research in information and computational technologies to provide decisive advantage for U.S. national security. Priority thrusts include: Transformative AI; resilient, adaptable, and secure software and complex systems; offensive and defensive cyber security and privacy; and fighting in the information domain. Proposals must go beyond incremental improvements to current state of the art.

Executive Summary:

DARPA’s Information Innovation Office (I2O) Office-Wide BAA invites proposals for multiple awards to develop revolutionary information and computational technologies in areas such as transformative AI, resilient and secure software, cyber operations, and information-domain capabilities. Abstracts may be submitted on a rolling basis until November 1, 2026, and full proposals until November 30, 2026.

How much funding would I receive?

DARPA does not publish fixed award amounts for this BAA. I2O funds a limited number of proposals, and budgets are determined by the technical approach, the scope of work, and alignment with I2O priorities.

What could I use the funding for?

The Information Innovation Office (I2O) creates groundbreaking science and delivers future capabilities in the information and computational domains to surprise adversaries and maintain enduring advantage for national security. I2O efforts typically address one or more of the following key thrust areas:

Are there any additional benefits I would receive?

Beyond the direct award, DARPA funding offers significant strategic advantages:

Government Validation and Credibility:
Receiving a DARPA award signals exceptional scientific and engineering merit, which accelerates engagement with primes, integrators, strategic partners, and investors.

Enhanced Visibility and Notoriety:
DARPA programs are frequently highlighted in federal communications, technical conferences, and defense media—boosting your company’s profile across the national security sector.

Ecosystem Access and Collaboration Opportunities:
Awardees gain access to DARPA program managers, government labs, test ranges, and a high-level innovation network—opening doors to future contracts and partnerships.

Stronger Exit and Acquisition Potential:
Nondilutive funding that matures breakthrough technology, combined with the DARPA “stamp,” often increases valuation and attractiveness to large defense, aerospace, semiconductor, and AI-focused acquirers.

What is the timeline to apply and when would I receive funding?

Abstracts: May be submitted on a rolling basis until November 1, 2026, at 5:00 p.m. Eastern.

Full proposals: May be submitted on a rolling basis until November 30, 2026, at 5:00 p.m. Eastern.

The BAA does not specify dates for award decisions or when funding would be released; those depend on DARPA’s evaluation and negotiation timelines.

Where does this funding come from?

Funding comes from the U.S. Department of Defense through the Defense Advanced Research Projects Agency (DARPA), specifically the Information Innovation Office (I2O).

Who is eligible to apply?

The BAA does not restrict eligibility. Typical DARPA BAAs accept proposals from:

  • U.S. businesses of any size

  • Universities

  • Nonprofits

  • Federally-funded research and development centers (with limitations)

Foreign entities may be subject to additional restrictions depending on classification and export-control considerations.

What companies and projects are likely to win?

The evaluation criteria (in descending order of importance) are:

  • Overall Scientific and Technical Merit

    • Innovative, feasible, and complete technical approach.

    • Team expertise and experience aligned with proposed tasks.

    • Clear deliverables and logical task sequence.

    • Identification and credible mitigation of key technical risks.

  • Potential Contribution and Relevance to the DARPA Mission

    • Strengthens the national security technology base.

    • Supports DARPA’s mission to make pivotal early technology investments that create or prevent technological surprise.

  • Plans to Implement Resilient Software (when applicable)

    • Clear capability to design, implement, and deliver resilient software.

    • Ensures interoperability, security, and ability to meet DoD/DARPA mission objectives.

    • Uses formal methods when appropriate to work toward eliminating software vulnerabilities.

  • Cost Realism

    • Costs are realistic and consistent with the technical approach and Statement of Work.

    • Effort leverages relevant prior research to maximize benefit from available funding.

Are there any restrictions I should know about?

  • Abstract requirement: A proposal will not be reviewed unless an abstract has been submitted and DARPA has issued an invitation to propose.

  • Scope of work: Proposers may not propose work that they have already completed or that has already received funding or a positive funding decision from DARPA or another Government agency.

  • Revolutionary advances only: Research that primarily yields evolutionary improvements to existing state of the art is explicitly excluded.

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive submission under this BAA will likely take 120–160 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available to submit an abstract for a flat fee of $5,000.

Fractional support is $300 per hour, with most DARPA proposal projects requiring 80–100 hours of expert support from strategy through submission of full proposal.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More
Inactive Josiah Wegner Inactive Josiah Wegner

DARPA Microsystems Technology Office (MTO) Office-Wide BAA

Deadline: January 15, 2026

Funding Award Size: Est. $2 million

Description: DARPA’s Microsystems Technology Office (MTO) is seeking high-risk, high-reward research ideas that revolutionize microelectronics, integrated circuits, photonics, quantum systems, biological circuits, and manufacturing ecosystems. This office-wide BAA targets breakthrough microsystems that create or prevent strategic surprise for national security.

Below is a brief summary. Please check the full solicitation before applying (link in resources section).

Executive Summary:

DARPA’s Microsystems Technology Office (MTO) is offering funding for revolutionary research across microelectronics, photonic circuits, quantum systems, biological/organic circuits, advanced manufacturing ecosystems, and dual-use microsystems. Multiple awards are anticipated, with no predefined funding limits. Abstracts are accepted until January 15, 2026, and proposals until March 2, 2026.

How much funding would I receive?

Funding amount is flexible. DARPA anticipates multiple awards, and efforts may span basic research (6.1), applied research (6.2), or advanced technology development (6.3). Proposers can also elect an Accelerated Award Option for awards under $2 million with 30-day award timelines.

What could I use the funding for?

Research areas of current interest to MTO include, but are not limited to, the following topics:

  • Quantum circuits

    1. Interconnect technologies for transferring quantum states between qubit platforms

    2. Generalizable improvements for processing chain for all types of quantum sensors

    3. High density low loss mixed signal transfer between room and quantum temperatures

  • Biological circuits

    1. High throughput molecular readers for full spectrum sequencing

    2. 3-dimensional bio-templated self-assembly of microsystems

    3. Highly-parallel DNA writing platforms for long DNA writes for genome-scale complexity with low error

  • Photonic circuits

    1. Applications for purely photonic circuits not realizable in electronic circuits

    2. Chip scale photonics for ultralow noise microwave sources

    3. Tunable chip scale ultrafast (<10 ps) lasers

    4. Fiber-inspired ultralow loss integrated photonics

  • Manufacturing Ecosystem

    1. Litho- and etch-free direct nanoscale semiconductor manufacturing

    2. Low-loss high permeability/permittivity materials

    3. High density cryogenic-to-room-temperature interconnects

    4. Atomically precise, multi-chemistry molecular manufacturing technologies

    5. Energy reclamation from low-grade waste heat

    6. Reconfigurable multiscale manufacturing for onshore manufacturing

  • Dual Use by Design

    1. All-weather long distance high bandwidth communications

    2. Commercially relevant tool development challenge problems

    3. Conformal and malleable batteries

    4. Design and assembly of complex microsystems in supply-chain-free environments

    5. Reconfigurable additive manufacturing for multiple classes of materials

    6. Context aware imaging

Are there any additional benefits I would receive?

Beyond direct funding, awardees gain significant strategic advantages:

Government Validation & Credibility
DARPA selection signals elite technical quality and national-security relevance — often accelerating partnerships with primes, OEMs, and investors.

Enhanced Market Visibility
Awards frequently lead to increased visibility through DARPA communications, publications, and industry attention.

Ecosystem Access & Collaboration
Awardees join a national innovation community spanning quantum, photonics, microelectronics, and advanced materials — opening doors to long-term collaborations and follow-on opportunities.

Stronger Exit & Acquisition Potential
Non-dilutive support enables deep tech maturation without equity loss. Companies validated by DARPA historically see improved valuation, stronger commercial traction, and increased acquisition interest.

What is the timeline to apply and when would I receive funding?

Abstract Deadline: January 15, 2026, 1:00 PM ET

Proposal Deadline: March 2, 2026, 1:00 PM ET

DARPA reviews proposals on a rolling basis.

If you select the Accelerated Award Option (<$2M projects), DARPA may issue an award within 30 days of selection notification.

Where does this funding come from?

Funding comes from the Defense Advanced Research Projects Agency (DARPA) under the Microsystems Technology Office (STO).

Who is eligible to apply?

The BAA does not restrict eligibility. Typical DARPA BAAs accept proposals from:

  • U.S. businesses of any size

  • Universities

  • Nonprofits

  • Federally-funded research and development centers (with limitations)

Foreign entities may be subject to additional restrictions depending on classification and export-control considerations.

What companies and projects are likely to win?

DARPA will select proposals that score highly on scientific merit, mission relevance, and cost realism.

  • High Scientific & Technical Merit: Innovative, feasible, and well-justified approaches with clear deliverables, identified risks and credible mitigations, and a team with the expertise to execute.

  • Strong Contribution to DARPA’s Mission: Efforts that meaningfully advance U.S. national security capabilities, show a credible transition path to U.S. defense applications, and include an IP strategy that does not hinder government use.

  • Realistic, Well-Substantiated Costs: Budgets that accurately reflect the level of effort, materials, labor, and technical scope—avoiding artificially low estimates and demonstrating efficient use of prior research and existing capabilities.

Are there any restrictions I should know about?

  • Research must be revolutionary, not incremental.

  • CMMC Level 2 is required for procurement contracts beginning Nov 10, 2025.

  • Foreign influence and security review applies to fundamental research teams.

  • Classified submissions require coordination with DARPA security.

  • Export control and CUI restrictions apply.

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive submission under this BAA will likely take 120–160 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $5,000 for the Abstract Submission.

Fractional support is $300 per hour, with most DARPA proposal projects requiring 80–100 hours of expert support from strategy through submission of full proposal.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More
Inactive Josiah Wegner Inactive Josiah Wegner

Autonomous Interventions and Robotics (AIR) – ARPA-H-SOL-26-146

Deadline: January 26, 2026

Funding Award Size: $2M+

Description: The Autonomous Interventions and Robotics (AIR) program funds development of autonomous robotic surgery technologies in two major areas: (1) fully autonomous endovascular robotic systems for procedures like thrombectomy and embolization, and (2) untethered, autonomous interventional microbots that can diagnose and treat disease with minimally invasive access.

Below is a summary. Please see the official solicitation on sam.gov for details (link in Resources Section).

Executive Summary:

The AIR program will award multiple OT agreements to teams developing autonomous endovascular robotic systems and interventional microbots that can perform key parts of surgical and interventional procedures without direct human control. The program runs for five years (two-year Phase 1 and three-year Phase 2). Companies must submit a Solution Summary by January 26, 2026 and a Full Proposal by March 30, 2026.

How much funding would I receive?

The ISO does not specify a minimum or maximum award amount. ARPA-H states only that it expects to make multiple OT awards under this opportunity; budgets will be driven by the scope, risk, and duration of each proposed 5-year effort (2-year Phase 1 + 3-year Phase 2).

What could I use the funding for?

The Autonomous Interventions and Robotics (AIR) program aims to catalyze the development of autonomous robotic surgery—an intervention during which a robot performs part, or all, of the procedure without direct human input. AIR encompasses two (2) technical areas: Technical Area 1 (TA1)—endovascular robotics, and Technical Area 2 (TA2)—microbots. Technical Area 1 comprises sub-areas TA1-A—endovascular robotic systems and TA1-B—endovascular simulation environment.

Are there any additional benefits I would receive?

Beyond direct funding, AIR awards can provide strategic benefits typical of ARPA-style programs:

  • Government technical validation: Being selected by ARPA-H signals that your approach is technically ambitious and nationally relevant in health innovation and surgical autonomy, which can help in discussions with strategics, hospital systems, and investors.

  • Positioning for regulatory and ecosystem engagement: AIR is structured with parallel FDA collaboration (for TA1) and explicit regulatory milestones (e.g., simulation frameworks, Q-submissions) that can de-risk later clinical and commercialization steps.

  • Access to a high-end performer network: Performers will interact with other top robotics, imaging, and microbotics teams, plus FDA scientific collaborators and ARPA-H program staff—often leading to follow-on partnerships and future solicitations.

  • Nondilutive growth capital: Because funding is nondilutive, successful teams can mature high-capex platforms (robotics, microfabrication, imaging) while preserving equity and potentially driving higher valuations and stronger exit options down the line.

What is the timeline to apply and when would I receive funding?

  1. Proposer’s Day: December 16, 2025

  2. Q&A deadline: January 20, 2026, 5:00 PM ET

  3. Solution Summaries due: January 26, 2026, 5:00 PM ET

  4. Full Proposals due: March 30, 2026, 5:00 PM ET

Where does this funding come from?

The Advanced Research Projects Agency for Health (ARPA-H), a federal R&D agency within HHS, issuing awards under the authority of 42 U.S.C. § 290c(g)(1)(D) via OT agreements.

Who is eligible to apply?

  • Universities and other educational institutions

  • Non-profit organizations

  • Small businesses

  • Other-than-small businesses

What companies and projects are likely to win?

  1. Overall Scientific & Technical Merit:
    Companies proposing highly innovative, technically rigorous, and fully executable plans with well-defined milestones, clear risk-mitigation strategies, and IP structures that enable commercialization are most competitive. Winning projects will demonstrate a credible path to achieving AIR’s demanding 5-year technical milestones.

  2. Proposer’s Capabilities & Related Experience:
    Teams with deep, directly relevant expertise—including experienced robotics engineers, imaging specialists, microbot developers, and required clinicians (e.g., an endovascular neurosurgeon for TA1-A)—are most likely to win. Prior success delivering complex R&D programs on time and on budget is a major advantage.

  3. Assessment of Proposed Cost/Price:
    ARPA-H will favor proposers who submit realistic, well-justified budgets that reflect the true complexity of autonomous surgical robotics or microbot development. Costs must align with the technical plan, leverage past research efficiently, and avoid artificially low budgets or staffing junior personnel simply to reduce cost.

Are there any restrictions I should know about?

  • Key restrictions from the ISO include:

    • Scope restrictions

      • TA1 excludes autonomous vascular access and closure; a human must obtain vessel access.

      • GI “pill camera–only” devices and ingestible microbots that only image, stimulate, or deliver cargo are out of scope; GI microbots must at least sense and biopsy, or sense/biopsy/ablate, to qualify.

      • Purely biological, purely chemical, or chem-bio-only delivery concepts (no mechanical/electronic component) are not acceptable microbots. Nanoparticles alone are out of scope.

    • Team composition and application rules

      • TA1-A teams must include at least one endovascular neurosurgeon.

      • A given team may propose to either TA1-A or TA1-B, but not both

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive solutions summary under this BAA will likely take 40–60 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $4,000 to submit a solution summary.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

Check the full solicitation here.

Read More
Inactive Josiah Wegner Inactive Josiah Wegner

DIU Project Janus – Advanced Nuclear Microreactor Power Plant Prototyping

Deadline: December 15, 2025

Funding Award Size: $20 Million+

Description: The U.S. Army and DIU seek commercial partners to design, prototype, and deliver first-of-a-kind (FOAK) and second-of-a-kind (SOAK) Microreactor Power Plants (MPP) capable of providing continuous, resilient, 30-year nuclear power for military installations and defense missions. Demonstrations must occur on a U.S. Army installation by 2030.

Executive Summary:

Project Janus is soliciting commercial solutions to design, prototype, and deploy advanced nuclear Microreactor Power Plants (MPPs) that can provide continuous, resilient power across Army installations. Awarded vendors will prototype both a First-of-a-Kind (FOAK) and a Second-of-a-Kind (SOAK) MPP, leading to potential follow-on production and long-term power purchase agreements. Solution Briefs are due December 15, 2025, so companies should begin preparing ASAP.

How much funding would I receive?

DIU does not publish fixed award amounts, but nuclear prototyping OTAs typically fall within the multi-million to tens-of-millions range, depending on complexity and vendor contributions.

Importantly, DIU OTAs can lead directly to large follow-on production contracts or long-term electricity PPAs without further competition, enabling far greater lifetime contract value.

What could I use the funding for?

Problem Statement

Ensuring consistent, resilient energy across military installations and operational theaters has become an increasingly complex challenge for the U.S. military. Aging infrastructure, dependence on vulnerable civilian power grids, complex liquid fuel logistics, and rising energy demands from advanced technologies all threaten mission assurance. Frequent electricity outages, grid disruptions, and limited backup capacity jeopardize critical systems responsible for command, control, communications, and logistics. This directly undermines readiness, training, and operational effectiveness. These vulnerabilities underscore the urgent need for secure, scalable, and independent energy solutions that ensure continuous power for the warfighter to operate anytime, anywhere, regardless of external grid instability or supply chain disruptions.

The U.S. Army, alongside the Defense Innovation Unit, seeks to prototype Microreactor Power Plant(s) (MPPs) capable of developing a suite of advanced nuclear power plant energy solutions to meet the needs of the U.S. Department of War (DoW). These MPPs will leverage recent advances in the nuclear industry to provide continuous and reliable power in all DoW scenarios and will be demonstrated on a military installation within the United States by 2030.

Background

On 23 May 2025, four executive orders (EOs) were issued that aimed at modernizing America’s nuclear energy posture, with direct implications for the Army and the broader DoW. In particular, EO 14299 Deploying Advanced Nuclear Reactor Technologies for National Security, states that “it is the policy of the United States to ensure the rapid development, deployment, and use of advanced nuclear technologies to support national security objectives, such as the protection and operation of critical infrastructure, critical defense facilities, and other mission capability resources.” These orders represent a strategic shift towards immediately and impactfully leveraging advanced nuclear technologies. Meeting the objectives of EO14299 requires a focus on both installation and operational energy goals through a coordinated prototype program that leverages MPP technologies to address the Department of War’s energy needs. 

Project Approach

The broader Department of the Army’s Janus program objective is to develop a suite of prototype solutions for MPPs that can supply power for both installations and non-permanent operations. The Janus project approach under the DIU CSO will use an iterative prototype development process to provide a clear path to transition of the successful commercially demonstrated technology solutions. “Suite” refers to the DoW’s intent to select multiple reactor designs for the OTA Agreement, each to be paired with an Army installation by the Army after contract award. This will involve prototyping a First of a Kind (FOAK) MPP under the Army’s regulatory authority, followed shortly after by a Second of a Kind (SOAK) MPP, also using the Army’s regulatory authority. The Department is seeking fission-based solution sets for installation and defense purposes. 

Vendors will be paired with Army installations after the OTA contract award. Vendors will develop their FOAK prototype for demonstration on that installation and commence design of the SOAK prototype near the end of FOAK design. The SOAK prototype is expected to build on lessons learned from the FOAK and include design changes from the FOAK prototype, through iterative prototyping. 

Vendor solutions submitted under the AOI are highly encouraged to use the FOAK and SOAK approach in their proposals, and discuss the path from SOAK to Nth-of-a-kind production. Solutions may utilize the operating life of both the FOAK and SOAK MPPs in series to reach the 30-year lifetime power generation, assuming continuity of power across the 30-year period. 

The Army will be announcing the selection of the initial group of installations for the Janus project MPP prototypes at a later date. Vendors are prohibited from contacting or responding to queries from the installations regarding any aspect of CSO HQ084520SC001 or the Janus project. Vendors who do not comply with the prohibition may be removed from participation in the Janus Project. 

Project Objectives

The Department is seeking solution briefs for the full lifecycle of MPPs that would notionally start operations at an Army installation located in the United States before the end of calendar year 2030. Solution briefs should include all stages of an MPP’s lifecycle: design, testing, regulation, construction, operations, deconstruction, and returning the site to an unrestricted release status.

The objectives of the prototype include: 

  • Provide mission assurance through energy resilience for a range of defense applications. 

  • Assemble and operate prototype MPPs on military installations within the United States to demonstrate the capability of the MPP designs to provide safe, secure, reliable, and environmentally compliant electricity and thermal energy (if needed) in support of readiness goals for mission critical assets.

  • Engage with the government and privatized distribution providers, transmission providers, and commodity providers currently serving U.S. Military installations to facilitate seamless and resilient energy regardless of commercial grid conditions.

Final solutions will follow a process under the U.S. Army Regulatory Authority for the entire lifecycle. The U.S. Army’s regulatory authority is derived from section 91b of the Atomic Energy Act (42 U.S.C. § 2121(b)), as implemented pursuant to the Presidential Directive of 23 September 1961. Vendors will follow the Army regulatory process as documented in AR 50-7 (2016), although additional guidance will be provided during Phase 2 and throughout the FOAK design. AR 50-7 can be found at: https://armypubs.army.mil/epubs/DR_pubs/DR_a/pdf/web/r50-7_Web_FINAL.pdf. 

Awarded vendors will be given opportunities to provide feedback on gaps in Army regulatory processes as additional regulatory guidance is provided. Additional regulatory requirements, such as transportation of nuclear material on public highways, should be addressed by Vendors during their proposals.

Reviews and implementation during the MPP prototype development process will include an integrated and phased approach to compliance with planning and design, planning and construction, architecture and engineering, building construction, environmental, operating, safety and physical/cyber protection, emergency response planning, deconstruction, and spent fuel management requirements. 

A successful MPP prototype will provide a sound and demonstrated technological solution for commercial operations. A successful prototype will complete fuel load and testing phases and will be permitted by the Army Regulator to begin normal operations. The OTA prototype will transition to unrestricted operations as a COCO MPP with a Power Purchase Agreement (PPA), production OTA, or other Federal Acquisition Regulation (FAR) based contract.

Desired Solution Features 

Desired solution features include the following attributes and capabilities: 

  • Incorporates nuclear fuel that is enriched to 20% or less U-235 and that is legal for defense purposes. The fuel must be qualified, available, and fabricated on a timeline that will meet program timelines.  

    • Defense-purpose feedstock may be made available as Government Furnished Equipment (GFE) for FOAK and SOAK MPPs through an Army fuel allocation process. If feedstock is provided as GFE, vendors will be responsible for transportation, blending, and fabrication of the fuel. 

    • Vendors should address the implications of a) the Government not providing feedstock as GFE, b) of the Government providing feedstock as GFE for only the first fueling, and c) the Government providing feedstock as GFE for the operational life of the MPP.

  • Capable of producing electrical power in the range of kW-level up to 20MWe (up to 60 MWth). Capable of local control and dispatch and integrated to the greatest extent practicable into existing infrastructure, operations centers (if applicable), workflows, and operations and maintenance systems. 

  • Capable of startup/shutdown and monitoring operations both with and without commercial power availability (both black start and grid-connected start capability). 

  • Capable of MPP operations with a commercial power connection, and an alternative credited independent power source as a backup. 

  • The MPP should be operated only from the control room located within the Army installation (remote or wireless operation is not allowed). 

    • MPPs with remote maintenance and diagnostics capabilities that comply with relevant cybersecurity U.S. Government standards, e.g., NIST 800-171 Rev. 2 for Federal Contractors, may be considered. 

    • The MPP control room must be designed to accommodate two operators, with space for an additional person, at a minimum. 

  • The MPP design should include passive safety features to the extent practical to ensure MPP key safety functions are satisfied under all conditions, states, and modes. 

  • Radiation exposure at the MPP site boundary should not exceed the limits provided in 10 CFR 20 during routine operations. Proposals must sufficiently account for relevant factors, including sky shine, emissions from activated site materials, and surrounding buildings at various elevations around the site boundary. 

  • The MPP design must address Natural Hazard Phenomena, including seismic loads, external floods, and other potential hazards.

  • The MPP design must have clearly articulated systems and safety case approaches, including an initial set of proposed design criteria and design safety strategy.

  • Vendor strategy and capability to continuously provide full power supply for up to 30 years, including operations, maintenance, sustainment, and refueling activities. 

    • There are no restrictions on the proposed strategy to achieve 30-years of continuous power (e.g., refueling or ‘replaceable’ modules to maintain continuity of operations). 

    • The overall lifecycle strategy of the MPP by the Vendor will be evaluated and must include associated costs/risks with the proposed strategy for long-term operations.

  • Non-core irradiated material should be removed or qualified for unrestricted release within 2 years upon completion or termination of the power production contract. An initial irradiated material disposal plan, along with an associated finance structure, must be approved by the Army before design permitting. 

  • Irradiated core material should be removed from the site notionally within 5 years of completion or termination of the power production contract, or as otherwise agreed upon by the Army. An initial core decommissioning plan, along with an associated finance structure, must be approved by the Army before MPP operations are permitted. 

  • A target site area should be sized appropriately for FOAK (and SOAK if co-located) to ensure compliance with Federal radiation limits in 10 CFR 20 and the anticipated Seismic Design Category. Selected Vendors will be paired with an installation post-OTA award.

  • Reasonable and appropriate safety, physical, cyber, and safeguards measures should be implemented in the design consistent with best practices. Army-specific requirements will be provided to vendors invited to participate in Phase 2 Pitches. 

  • In addition to the above desired solution features, solutions must address the aspects below: 

    • A nuclear supply chain for nuclear-grade equipment that is clearly identified and credibly available to supply equipment to meet the notional timeline. The nuclear supply chain identified must meet defense-purpose limitations; any part of the nuclear supply chain reliant on international sources must be identified and mitigated with a plan approved by the Army.

    • Technology Readiness Level (TRL) and Manufacturing Readiness Level (MRL) for equipment included in the design. The TRL and MRL readiness levels will be evaluated in depth during Phase 2 Pitches. 

    • Identified gaps in available Computational analytical tools, Codes, or Standards accepted for nuclear use. Identified analytical tools, Codes, or Standards for which the design will operate outside the approved range 

    • (e.g., the MPP operates at a higher temperature than existing foundational data).

    • Identified gaps in available material performance data for safety or reliability-related equipment under anticipated operating conditions.

    • Plans and approaches to move from FOAK to SOAK, to Nth-of-a-Kind development and production. Plans to commercialize or develop commercial versions of proposed MPP prototype designs.

    • Long-term plans for fuel acquisition and manufacturing, including the status of negotiations or agreements with miners, enrichers and/or fabricators. 

Are there any additional benefits I would receive?

Beyond direct prototype funding, awardees gain substantial strategic advantages:

Government Validation & National Credibility
Winning a DIU/Army nuclear award signals unmatched credibility in defense nuclear innovation. This accelerates alignment with primes, utilities, and capital markets.

Path to Long-Term, Non-Dilutive Revenue
Successful prototypes can transition into 30-year Power Purchase Agreements, production OTAs, or FAR contracts, representing massive long-term revenue potential.

Increased Market Visibility
Awardees gain visibility across DoD, DOE, and national energy/security communities—often resulting in media coverage and faster customer traction.

Supply Chain & Regulatory Acceleration
Participation provides exposure to Army regulators, national labs, nuclear fuel providers, and defense-focused supply chain partners—accelerating commercialization beyond the defense market.

Higher Exit and Valuation Potential
Nondilutive support for FOAK/SOAK nuclear builds significantly increases company valuation, technical defensibility, and acquisition potential for defense, energy, and infrastructure buyers.

What is the timeline to apply and when would I receive funding?

  • Solution Brief Due: December 15, 2025

  • DIU Review: ~30 days for down-select

  • Phase 2 Pitch: Invitation-only, early 2026

  • Full Proposal (Phase 3): Following successful pitch

  • Prototype Awards: Rolling upon approval and funding availability

  • FOAK Operation Goal: Before end of 2030

  • SOAK Development: Begins near completion of FOAK design

Where does this funding come from?

Project Janus is funded through the U.S. Army and executed under the Defense Innovation Unit's Commercial Solutions Opening (CSO) process. Awards are made using Other Transaction Agreements (OTAs) under 10 U.S.C. § 4022 (formerly § 2371b).

Who is eligible to apply?

U.S. and foreign-owned commercial companies

  • Companies proposing fission-based microreactor designs

  • Teams including reactor designers, fabricators, integrators, fuel cycle partners

  • Vendors able to provide private financial contributions (projects relying solely on government funds are not eligible)

  • Vendors able to comply with Section 889 and Army nuclear regulatory requirements

Multiple submissions and teaming arrangements are allowed.

What companies and projects are likely to win?

Competitive applicants will:

  • Demonstrate credible, deployable microreactor designs at TRL/MRL levels suitable for FOAK prototyping

  • Present a robust plan for 30 years of operations, including refueling or replaceable module strategies

  • Show credible nuclear supply chain access for fuel, components, and safety-critical systems

  • Provide a realistic path from FOAK → SOAK → Nth-of-a-kind commercialization

  • Demonstrate ability to meet Army regulatory requirements under AR 50-7

  • Provide private cost share or financial contributions, as required in Phase 2

  • Address cybersecurity, safety, passive safety features, and natural hazard requirements

  • Show strong corporate viability and commercial market strategy (a key DIU evaluation factor)

Are there any restrictions I should know about?

  • Remote or wireless operation of the MPP is not allowed; control room must be on-installation

  • Vendors may not contact Army installations

  • All proposals must be unclassified; CUI is not allowed

  • Foreign-owned firms must be able to secure necessary clearances

  • Vendors must address implications of fuel as GFE vs. vendor-supplied

  • Submissions must comply with Army radiation exposure limits and 10 CFR 20

  • Private financing participation is required to advance to Phase 2 and Phase 3

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive solutions brief will take 50-75 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.

How much would BW&CO Charge?

Our full service support is available for the Solution Brief for $5000. Pitch & Full proposal quoted upon invitation.

Fractional support is $300 per hour.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

View the Solicitation Here.



Read More
Inactive Josiah Wegner Inactive Josiah Wegner

DARPA Strategic Technology Office-Wide Broad Agency Announcement (BAA)

Deadline: December 19, 2025

Funding Award Size: Est. $2 million

Description: DARPA’s Strategic Technology Office (STO) is seeking revolutionary, high-risk research ideas that can create new mission-level capabilities across air, space, sea, land, and the electromagnetic spectrum. This BAA supports disruptive systems, devices, or architectures that go beyond incremental improvements and are not already covered under existing STO programs.

Executive Summary:

DARPA’s Strategic Technology Office (STO) BAA is soliciting breakthrough research concepts that create new mission-level capabilities beyond the current state of practice. The agency will fund a limited number of high-risk, high-reward proposals across a broad range of defense and national-security technical domains. Applications are due December 19, 2025.

How much funding would I receive?

DARPA does not publish fixed award amounts for this BAA. STO funds a limited number of proposals, and budgets are determined by the technical approach, the scope of work, and alignment with STO priorities.

What could I use the funding for?

DARPA's STO seeks innovative ideas and disruptive technologies that provide the U.S. military and national security leaders with trusted, disruptive capabilities across all physical domains (Air, Space, Sea, and Land) and across the spectrum of competition. STO programs deliver solutions at speed and scale for today's warfighters while developing the resilient "breakthrough" systems and technologies needed for future battlespaces. STO does not focus on one area of responsibility or phenomenology. Rather, STO programs capture the strategic, logistical, and tactical complexity of today's national security environments. STO is a "systems office" seeking to create new "proof-of-concept" mission systems. Its goals are to develop and demonstrate new capabilities that expand what is technically possible.

Research areas of current interest to STO include, but are not limited to, the following topics:

  •  Acoustic communication and sensing

  •  Adaptability

  •  Advanced computing

  •  Additive manufacturing

  •  Architecture and advanced systems engineering

  •  Artificial intelligence

  •  Autonomy and control algorithms

  •  "Big data" analytics

  •  Combat identification

  •  Command and control (C2)

  •  Communications and networking, virtual and adaptive

  •  Complexity management

  •  Critical infrastructure defense

  •  Decision aids and C2 technology

  •  DevOps and novel software development and integration

  •  Directed energy (DE)

  •  Distributed autonomy and teaming (machine-machine, human-machine)

  •  Economic security

  •  Effects chain functions (disaggregated find, fix, finish, target, engage, assess)

  •  Electro-optic/infrared sensors

  •  Electromagnetic warfare (EW)

  •  High-frequency (HF) communications and sensing

  •  High voltage electric power systems and architecture

  •  Human behavior modeling

  •  Human-machine symbiosis

  •  Industrial engineering

  •  Integration and reliability technologies

  •  Interoperability

  •  Logistics

  •  Modeling and simulation

  •  Microwave and millimeter wave communications and sensing

  •  Novel kinetic effects

  •  Non-kinetic effects (EW, DE, cyber)

  •  Optical technologies

  •  Photonics

  •  Radio technologies (especially software-defined and novel waveforms and processing)

  •  Radar and adaptive arrays

  •  Resilient systems

  •  Robotics

  •  Seekers and other expendable sensors and processing

  •  Sensors and analytics

  •  Signal processing

  •  Space sensors, communications, autonomy, and architectures (especially supporting proliferated low earth orbit constellations)

  •  Strategy analysis technology

  •  Supply chain analytics

  •  System of systems

  •  Undersea and seabed technology

  •  Tactics development technology

  •  Testing and data collection

  •  Very low earth orbit (VLEO) technology

  •  Very low frequency (VLF) technology

Are there any additional benefits I would receive?

Beyond the direct award, DARPA funding offers significant strategic advantages:

Government Validation and Credibility:
Receiving a DARPA award signals exceptional scientific and engineering merit, which accelerates engagement with primes, integrators, strategic partners, and investors.

Enhanced Visibility and Notoriety:
DARPA programs are frequently highlighted in federal communications, technical conferences, and defense media—boosting your company’s profile across the national security sector.

Ecosystem Access and Collaboration Opportunities:
Awardees gain access to DARPA program managers, government labs, test ranges, and a high-level innovation network—opening doors to future contracts and partnerships.

Stronger Exit and Acquisition Potential:
Nondilutive funding that matures breakthrough technology, combined with the DARPA “stamp,” often increases valuation and attractiveness to large defense, aerospace, semiconductor, and AI-focused acquirers.

What is the timeline to apply and when would I receive funding?

Applications are due December 19, 2025.

DARPA does not publish a fixed award timeline.

Where does this funding come from?

Funding comes from the Defense Advanced Research Projects Agency (DARPA) under the Strategic Technology Office (STO), a DoD organization responsible for advanced mission-level systems and emerging technologies.

Who is eligible to apply?

The BAA does not restrict eligibility. Typical DARPA BAAs accept proposals from:

  • U.S. businesses of any size

  • Universities

  • Nonprofits

  • Federally-funded research and development centers (with limitations)

Foreign entities may be subject to additional restrictions depending on classification and export-control considerations.

What companies and projects are likely to win?

DARPA will select proposals that score highly on scientific merit, mission relevance, and cost realism.

  • High Scientific & Technical Merit: Innovative, feasible, and well-justified approaches with clear deliverables, identified risks and credible mitigations, and a team with the expertise to execute.

  • Strong Contribution to DARPA’s Mission: Efforts that meaningfully advance U.S. national security capabilities, show a credible transition path to U.S. defense applications, and include an IP strategy that does not hinder government use.

  • Realistic, Well-Substantiated Costs: Budgets that accurately reflect the level of effort, materials, labor, and technical scope—avoiding artificially low estimates and demonstrating efficient use of prior research and existing capabilities.

Are there any restrictions I should know about?

  • Proposals must not duplicate existing STO programs or other active STO BAAs.

  • Research that yields incremental or “evolutionary” improvements is specifically excluded.

  • Offerors are strongly encouraged to review current STO programs and speak with program managers before applying.

How long will it take me to prepare an application?

For a first-time applicant, preparing a competitive submission under this BAA will likely take 120–160 hours in total.

How can BW&CO help?

Our team specializes in complex federal R&D proposals and can:

  • Triple your likelihood of success through proven strategy and insider-aligned proposal development

  • Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations

  • Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth under Federal & State R&D Initiatives.

How much would BW&CO Charge?

Our full service support is available for a flat fee of $15,000 Project + a 5% Success Fee.

Fractional support is $300 per hour, with most DARPA proposal projects requiring 80–100 hours of expert support from strategy through submission of full proposal.

For startups, we offer a discounted rate of $250 per hour to make top-tier grant consulting more accessible while maintaining the same level of strategic guidance and proposal quality.

Additional Resources

See solicitation on sam.gov

Read More